STOCK TITAN

Swarmer Q3 2026 net loss widens to $9.31M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Swarmer, Inc. (SWMR) reported third-quarter 2026 revenue of $25,554 versus $35,771 a year earlier and a net loss of $9,314,440 versus $3,375,310. For the first nine months, revenue was $262,292 versus $284,681 and net loss was $21,098,313 versus $5,696,469. Q3 selling, general and administrative expense was $7,446,563 versus $139,343; research and development was $1,979,116 versus $641,686.

Cash and equivalents were $37,281,357 at September 30, 2026; operating activities used $17,469,016 over nine months. Management identified substantial doubt about continuing as a going concern, then concluded it was alleviated after issuing a delayed-draw note for up to $10.0 million on November 16, 2026. It said cash plus note availability would fund obligations for at least 12 months without ELOC proceeds or Ratel distributions. ELOC sales generated approximately $27.2 million gross through September 30, 2026.

The Ratel acquisition remained pending at quarter-end; stated closing consideration includes $7.2 million cash, subject to adjustment, and 1,064,942 shares, plus performance-based cash and shares. Stockholders approved the share issuance November 2, 2026. On November 10, 2026, Swarmer completed acquisition of 100% of a newly formed company holding Vataga Drone IP for $0.5 million and 393,701 shares, plus a revenue-based earnout. The SkyKnight counterparty group accounted for 100% of Q3 revenue and approximately 91% of nine-month revenue.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 4 points

How the balance works

Positive

  • None.

Negative

  • Major pointNet loss increased: Q3 $9,314,440 vs. $3,375,310; nine-month $21,098,313 vs. $5,696,469.
  • Major pointManagement identified substantial doubt before concluding the $10.0 million facility alleviated it. 7.8% of market cap
  • Moderate pointThe SkyKnight counterparty group accounted for 100% of Q3 revenue and approximately 91% of nine-month revenue.
  • Minor pointRevenue declined: Q3 $25,554 vs. $35,771; nine-month $262,292 vs. $284,681.

Filing Explained

As of the report’s issuance on November 16, 2026, no facility amount had been borrowed and no shares issued; future advances carry 7.00% annual interest, which may be added to the balance quarterly or, with the investor’s consent and subject to conditions, paid in shares, with amounts outstanding due January 16, 2028.

Third-quarter revenue $25,554 Three months ended September 30, 2026; $35,771 in 2025.
Third-quarter net loss $9,314,440 loss Three months ended September 30, 2026; $3,375,310 loss in 2025.
Nine-month revenue $262,292 Nine months ended September 30, 2026; $284,681 in 2025.
Nine-month net loss $21,098,313 loss Nine months ended September 30, 2026; $5,696,469 loss in 2025.
Cash and cash equivalents $37,281,357 As of September 30, 2026.
Net cash used in operating activities $17,469,016 Nine months ended September 30, 2026.
ELOC gross proceeds Approximately $27.2 million Aggregate proceeds from facility commencement through September 30, 2026.
Promissory Note facility Up to $10.0 million Delayed-draw facility issued November 16, 2026.
Equity Line of Credit financial
"entered into a common stock purchase agreement in connection with an Equity Line of Credit"
An equity line of credit is a loan that allows homeowners to borrow money against the value of their property, similar to having a flexible credit card secured by their home. It matters to investors because it provides a way for property owners to access cash for various needs, which can influence real estate markets and overall economic activity. This type of credit offers ongoing borrowing capacity, making it a valuable financial tool for those with significant property equity.
beneficial ownership limitation regulatory
"subject to a 4.99% beneficial ownership limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Level 3 measurement financial
"classified as a Level 3 measurement within the fair value hierarchy"
consideration payable to a customer financial
"accounted for as consideration payable to a customer"
contract liability financial
"presented as advances received under combined arrangement"
A contract liability is a legally binding obligation a company has under a contract to deliver goods, services, or a refund in the future in exchange for money or another benefit already received. Investors care because these obligations represent future cash outflows or performance risks—like an IOU on a household chore list—that can reduce available cash, affect earnings reliability, and change how risky or valuable a company’s financial position looks.
pre-funded warrant financial
"pre-funded warrants exercisable for shares of common stock"
A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were SWMR’s Q3 2026 revenue and net loss?

Swarmer reported third-quarter 2026 revenue of $25,554 and a net loss of $9,314,440 for the three months ended September 30, 2026. In the same 2025 quarter, revenue was $35,771 and net loss was $3,375,310.

How does SWMR’s equity line of credit work?

Under the June 10, 2026 agreement, Swarmer may sell up to 3,000,000 newly issued shares at its discretion over 24 months. Sales are priced at 98% of the volume-weighted average price determined under the agreement. The facility has a 4.99% beneficial ownership limit and, absent stockholder approval, an aggregate 2,240,930-share Exchange Cap.

What additional consideration could Ratel’s sellers receive?

Ratel’s sellers may earn up to an additional $7.2 million in cash upon achieving fiscal 2026 revenue and operating-income targets and up to an additional 4,422,125 common shares upon achieving targets for fiscal 2026 through 2028. Separately, Swarmer will pay $0.8 million in cash and grant 118,326 fully vested restricted stock units to Ratel employees at closing, with up to the same amounts if fiscal 2026 targets are achieved.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Q30002092574--12-31falseone44onehttp://fasb.org/srt/2026#ChiefExecutiveOfficerMember http://fasb.org/srt/2026#PresidentMember0002092574swmr:SkyKnightDroneProgramMemberswmr:MetaBureauLLCAndProgressTRWSROMember2026-04-012026-06-300002092574us-gaap:IPOMember2026-03-180002092574us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300002092574us-gaap:EmployeeStockOptionMember2026-07-012026-09-300002092574us-gaap:CommonStockMemberswmr:LucidCapitalMarketsLLCMember2026-06-012026-06-300002092574us-gaap:RestrictedStockMember2025-12-310002092574swmr:UnvestedStockOptionsExercisableForNominalConsiderationMember2025-07-012025-09-300002092574us-gaap:SubsequentEventMember2026-10-012026-10-010002092574us-gaap:ResearchAndDevelopmentExpense2025-07-012025-09-300002092574us-gaap:PreferredStockMemberus-gaap:ConvertiblePreferredStockMember2025-07-012025-09-300002092574swmr:SeriesA-1ConvertiblePreferredStockMember2025-09-222025-09-220002092574swmr:UnvestedStockOptionsExercisableForNominalConsiderationMember2026-07-012026-09-300002092574swmr:UAVDeploymentProgramAdvancePaymentMember2026-09-300002092574us-gaap:RetainedEarningsMember2026-09-3000020925742024-12-310002092574us-gaap:PerformanceSharesMemberswmr:ChairmanMember2026-01-012026-09-3000020925742025-09-300002092574us-gaap:RetainedEarningsMember2026-07-012026-09-300002092574us-gaap:CommonStockMember2025-12-310002092574us-gaap:DomesticCountryMember2026-01-012026-09-3000020925742025-12-310002092574us-gaap:DomesticCountryMember2025-07-012025-09-300002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310002092574swmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-06-102026-06-100002092574us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300002092574swmr:SeriesA-1ConvertiblePreferredStockMember2026-01-012026-09-300002092574us-gaap:CommonStockMembersrt:MaximumMemberswmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-06-152026-06-300002092574srt:MaximumMemberswmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-06-102026-06-1000020925742026-02-182026-02-180002092574swmr:PendingAcquisitionOfRatelRoboticsMember2026-09-300002092574us-gaap:TransferredAtPointInTimeMember2026-07-012026-09-300002092574us-gaap:PerformanceSharesMemberswmr:Non-EmployeeMember2025-12-012025-12-310002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300002092574us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMemberswmr:TwoThousandTwentySixStockPlanMember2026-01-012026-09-300002092574us-gaap:PreferredStockMemberus-gaap:ConvertiblePreferredStockMember2025-09-300002092574us-gaap:RestrictedStockMember2025-07-012025-09-3000020925742026-09-300002092574us-gaap:FairValueInputsLevel3Memberswmr:ELOCDerivativeMember2026-01-012026-09-300002092574us-gaap:TransferredAtPointInTimeMember2026-01-012026-09-300002092574srt:MinimumMemberus-gaap:MeasurementInputExpectedTermMember2026-09-300002092574us-gaap:WarrantMember2025-01-012025-09-300002092574us-gaap:TransferredOverTimeMember2026-01-012026-09-300002092574us-gaap:EmployeeStockOptionMember2025-01-012025-09-300002092574us-gaap:RetainedEarningsMember2025-01-012025-09-300002092574swmr:UAVDeploymentProgramAdvancePaymentMember2026-06-012026-06-300002092574us-gaap:DomesticCountryMember2026-07-012026-09-300002092574swmr:VatagaDroneMemberus-gaap:IntellectualPropertyMemberus-gaap:SubsequentEventMember2026-11-102026-11-100002092574us-gaap:SubsequentEventMember2026-11-102026-11-100002092574us-gaap:CommonStockMemberswmr:VatagaDroneMemberus-gaap:IntellectualPropertyMemberus-gaap:SubsequentEventMember2026-11-102026-11-100002092574swmr:UkraineUAVDeploymentProgramMember2026-06-252026-06-250002092574swmr:VatagaDroneMemberus-gaap:SubsequentEventMember2026-11-102026-11-100002092574us-gaap:SubsequentEventMembersrt:MaximumMember2026-11-102026-11-100002092574us-gaap:MeasurementInputOptionVolatilityMember2026-09-300002092574swmr:SupplierAgreementMember2026-07-012026-09-300002092574us-gaap:SubsequentEventMembersrt:MaximumMemberswmr:PromissoryNoteMember2026-11-160002092574us-gaap:RetainedEarningsMember2026-06-300002092574us-gaap:RestrictedStockMember2026-01-012026-09-300002092574us-gaap:WarrantMember2026-01-012026-09-300002092574us-gaap:TransferredOverTimeMember2026-07-012026-09-300002092574us-gaap:RestrictedStockMember2025-01-012025-09-300002092574swmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-06-100002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300002092574swmr:SeriesA-1ConvertiblePreferredStockMember2025-09-012025-12-310002092574swmr:UkraineUAVDeploymentProgramMember2026-09-300002092574us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300002092574swmr:VatagaDroneMemberus-gaap:IntellectualPropertyMemberus-gaap:SubsequentEventMember2026-10-262026-10-260002092574us-gaap:TransferredAtPointInTimeMember2025-01-012025-09-3000020925742025-04-012025-06-300002092574us-gaap:WarrantMemberswmr:SeriesA-1ConvertiblePreferredStockMember2025-12-310002092574us-gaap:TransferredAtPointInTimeMember2025-07-012025-09-300002092574us-gaap:RestrictedStockMember2026-09-300002092574us-gaap:WarrantMember2026-07-012026-09-300002092574us-gaap:CommonStockMember2024-12-310002092574swmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-06-102026-09-300002092574swmr:MemorandumOfUnderstandingWithVectusMember2026-08-012026-08-310002092574us-gaap:RestrictedStockMemberswmr:FounderMember2023-05-012023-05-310002092574us-gaap:WarrantMember2025-07-012025-09-300002092574us-gaap:IPOMember2026-07-012026-09-300002092574us-gaap:DebtInstrumentRedemptionPeriodOneMemberus-gaap:SubsequentEventMemberswmr:PromissoryNoteMember2026-11-162026-11-160002092574swmr:SeriesA-1ConvertiblePreferredStockMember2026-03-180002092574us-gaap:EmployeeStockOptionMember2026-01-012026-09-300002092574swmr:UAVDeploymentProgramMember2026-06-012026-06-300002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310002092574swmr:SkyKnightDroneProgramMemberswmr:MetaBureauLLCAndProgressTRWSROMemberswmr:PayableUponDeliveryMember2026-06-300002092574swmr:SeriesA-1ConvertiblePreferredStockMember2026-09-300002092574swmr:UnvestedStockOptionsExercisableForNominalConsiderationMember2025-01-012025-09-300002092574swmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-01-012026-09-300002092574us-gaap:CommonStockMember2026-09-300002092574us-gaap:CommonStockMember2026-06-300002092574us-gaap:RetainedEarningsMember2025-06-300002092574srt:MinimumMemberus-gaap:SubsequentEventMember2026-11-102026-11-100002092574swmr:DomainNameMember2026-09-300002092574swmr:SkyKnightDroneProgramMemberswmr:MetaBureauLLCAndProgressTRWSROMemberswmr:AmountPaidMember2026-06-300002092574us-gaap:SellingGeneralAndAdministrativeExpense2026-01-012026-09-300002092574us-gaap:PreferredStockMemberus-gaap:ConvertiblePreferredStockMember2026-09-300002092574us-gaap:SubsequentEventMemberswmr:PromissoryNoteMember2026-11-160002092574swmr:MeasurementInputProbabilityOfStayPrivateMember2026-09-300002092574us-gaap:AdditionalPaidInCapitalMember2026-09-300002092574swmr:InternetDomainNameSwarmerMember2026-05-012026-05-310002092574us-gaap:IPOMember2026-03-182026-03-180002092574swmr:FullyVestedRestrictedStockUnitsMemberswmr:PendingAcquisitionOfRatelRoboticsMemberswmr:RatelEmployeesMember2026-09-300002092574swmr:LucidCapitalMarketsLLCMember2026-07-012026-07-3100020925742025-01-012025-12-310002092574swmr:SeriesA-1ConvertiblePreferredStockMember2026-01-310002092574us-gaap:SellingGeneralAndAdministrativeExpense2025-01-012025-09-300002092574swmr:UnvestedStockOptionsExercisableForNominalConsiderationMember2026-01-012026-09-300002092574us-gaap:RetainedEarningsMember2026-01-012026-09-300002092574us-gaap:DebtInstrumentRedemptionPeriodThreeMemberus-gaap:SubsequentEventMemberswmr:PromissoryNoteMember2026-11-162026-11-160002092574us-gaap:CommonStockMemberswmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-01-012026-09-300002092574swmr:SeriesA-1ConvertiblePreferredStockMember2026-07-012026-09-300002092574us-gaap:CommonStockMembersrt:MaximumMemberswmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-06-152026-09-300002092574us-gaap:RestrictedStockUnitsRSUMemberswmr:PresidentAndChiefExecutiveOfficerMemberswmr:TwoThousandTwentySixStockPlanMember2026-03-182026-03-180002092574swmr:SkyKnightDroneProgramMember2026-01-012026-09-300002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-09-300002092574us-gaap:RestrictedStockUnitsRSUMember2026-09-300002092574swmr:SeriesA-1ConvertiblePreferredStockMember2026-01-012026-01-310002092574swmr:DomainNameMember2026-01-012026-09-300002092574us-gaap:ResearchAndDevelopmentExpense2025-01-012025-09-300002092574us-gaap:ResearchAndDevelopmentExpense2026-07-012026-09-300002092574us-gaap:AdditionalPaidInCapitalMember2025-09-3000020925742025-07-012025-09-300002092574us-gaap:CommonStockMember2025-07-012025-09-300002092574swmr:SeriesAConvertiblePreferredStockMember2026-03-180002092574swmr:UAVDeploymentProgramMember2026-09-300002092574swmr:PendingAcquisitionOfRatelRoboticsMember2026-09-090002092574swmr:SecretaryAndChiefExecutiveOfficerMemberus-gaap:RestrictedStockUnitsRSUMember2026-08-192026-08-190002092574swmr:VatagaDroneMemberus-gaap:SubsequentEventMembersrt:MaximumMember2026-11-102026-11-100002092574us-gaap:CommonStockMember2025-01-012025-09-300002092574us-gaap:AdditionalPaidInCapitalMember2025-06-300002092574us-gaap:PreferredStockMemberus-gaap:ConvertiblePreferredStockMember2025-01-012025-09-300002092574swmr:MeasurementInputProbabilityOfInitialPublicOfferingMember2026-09-300002092574us-gaap:DebtInstrumentRedemptionPeriodTwoMemberus-gaap:SubsequentEventMemberswmr:PromissoryNoteMember2026-11-162026-11-160002092574us-gaap:TransferredOverTimeMember2025-07-012025-09-3000020925742026-07-012026-09-300002092574us-gaap:PreferredStockMemberus-gaap:ConvertiblePreferredStockMember2026-01-012026-09-300002092574swmr:UAVDeploymentProgramMember2026-01-012026-09-300002092574swmr:SecretaryAndChiefExecutiveOfficerMemberus-gaap:RestrictedStockUnitsRSUMemberswmr:TwoThousandTwentySixStockPlanMember2026-03-182026-03-180002092574srt:MaximumMemberswmr:TwoThousandTwentySixStockPlanMember2026-09-300002092574us-gaap:SalesRevenueNetMemberswmr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-3000020925742025-01-012025-09-3000020925742026-01-012026-09-300002092574us-gaap:PerformanceSharesMemberswmr:ChairmanMember2026-07-012026-09-300002092574us-gaap:ResearchAndDevelopmentExpense2026-01-012026-09-300002092574us-gaap:SellingGeneralAndAdministrativeExpense2026-07-012026-09-300002092574us-gaap:ConvertiblePreferredStockMember2025-07-012025-09-300002092574us-gaap:SalesRevenueNetMemberswmr:CustomerOneMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300002092574us-gaap:RestrictedStockMember2026-07-012026-09-300002092574us-gaap:AdditionalPaidInCapitalMember2024-12-310002092574swmr:SeriesAConvertiblePreferredStockMember2026-09-300002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-09-300002092574swmr:SeriesA-1ConvertiblePreferredStockMember2025-09-220002092574us-gaap:RestrictedStockMember2026-01-012026-09-300002092574swmr:VatagaDroneMemberus-gaap:IntellectualPropertyMemberus-gaap:SubsequentEventMember2026-11-100002092574us-gaap:SellingGeneralAndAdministrativeExpense2025-07-012025-09-300002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300002092574us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMemberswmr:TwoThousandTwentySixStockPlanMember2026-01-012026-09-300002092574swmr:SeriesATwoThroughSeriesASixConvertiblePreferredStockMember2025-09-222025-09-220002092574swmr:SeriesATwoThroughSeriesASixConvertiblePreferredStockMember2026-03-180002092574swmr:IncentiveStockOptionsAndNon-StatutoryStockOptionsMember2026-01-012026-09-300002092574swmr:SkyKnightDroneProgramMember2026-04-012026-06-300002092574us-gaap:PerformanceSharesMemberswmr:ManagementExecutiveMember2026-09-012026-09-300002092574us-gaap:RetainedEarningsMember2025-09-300002092574swmr:SkyKnightDroneProgramMember2026-09-300002092574us-gaap:RestrictedStockUnitsRSUMemberswmr:TwoThousandTwentySixStockPlanMember2026-03-182026-03-180002092574us-gaap:ConvertiblePreferredStockMember2025-01-012025-09-300002092574us-gaap:CommonStockMember2025-09-300002092574us-gaap:DomesticCountryMember2025-01-012025-09-300002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-300002092574swmr:SkyKnightDroneProgramMemberswmr:MetaBureauLLCAndProgressTRWSROMemberswmr:PlatformIntegrationOperatingSystemMarketDevelopmentAndMarketingServicesMember2026-06-300002092574us-gaap:TransferredOverTimeMember2025-01-012025-09-300002092574swmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-06-090002092574us-gaap:CommonStockMember2025-06-300002092574swmr:SeriesAConvertiblePreferredStockMember2026-01-310002092574us-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-300002092574us-gaap:PerformanceSharesMemberswmr:ManagementExecutiveMember2025-12-012025-12-310002092574us-gaap:CommonStockMembersrt:MaximumMemberswmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-07-012026-09-300002092574swmr:UkraineUAVDeploymentProgramMember2026-06-2500020925742025-06-3000020925742026-06-300002092574us-gaap:RestrictedStockUnitsRSUMember2026-07-012026-09-300002092574us-gaap:AdditionalPaidInCapitalMember2026-06-300002092574us-gaap:RestrictedStockUnitsRSUMember2025-12-310002092574swmr:SkyKnightDroneProgramMemberswmr:MetaBureauLLCAndProgressTRWSROMember2026-06-012026-06-300002092574swmr:InternetDomainNameSwarmerMember2026-05-310002092574swmr:TwoThousandTwentySixStockPlanMember2026-09-300002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300002092574swmr:SkyKnightDroneProgramMemberswmr:MetaBureauLLCAndProgressTRWSROMember2026-06-300002092574us-gaap:AdditionalPaidInCapitalMember2025-12-3100020925742026-11-1000020925742025-10-310002092574us-gaap:PreferredStockMemberus-gaap:ConvertiblePreferredStockMember2025-12-310002092574swmr:SeriesA-1ConvertiblePreferredStockMember2025-12-310002092574us-gaap:SubsequentEventMemberswmr:PromissoryNoteMember2026-11-162026-11-160002092574us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300002092574swmr:SeriesAConvertiblePreferredStockMember2026-01-012026-01-310002092574us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-300002092574swmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-07-012026-09-300002092574us-gaap:CommonStockMember2026-07-012026-09-300002092574us-gaap:CommonStockMember2026-01-012026-09-300002092574us-gaap:EmployeeStockOptionMember2025-07-012025-09-300002092574swmr:JKLandVehiclesMember2026-09-090002092574us-gaap:RetainedEarningsMember2025-12-310002092574swmr:PurchaseAgreementMemberswmr:LucidCapitalMarketsLLCMember2026-06-152026-09-300002092574us-gaap:SubsequentEventMember2026-10-010002092574us-gaap:RestrictedStockUnitsRSUMemberswmr:ChiefProductAndTechnologyOfficerMemberswmr:TwoThousandTwentySixStockPlanMember2026-09-162026-09-160002092574swmr:SkyKnightDroneProgramMemberswmr:MetaBureauLLCAndProgressTRWSROMember2026-09-302026-09-300002092574us-gaap:PerformanceSharesMember2026-07-012026-09-300002092574us-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-300002092574swmr:SeriesAConvertiblePreferredStockMember2026-03-170002092574us-gaap:IPOMemberus-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300002092574us-gaap:RetainedEarningsMember2025-07-012025-09-300002092574us-gaap:FairValueInputsLevel3Memberswmr:ELOCDerivativeMember2025-12-310002092574us-gaap:RetainedEarningsMember2024-12-310002092574us-gaap:FairValueInputsLevel3Memberswmr:ELOCDerivativeMember2026-09-300002092574us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-300002092574swmr:SeriesATwoThroughSeriesASixConvertiblePreferredStockMember2025-09-22xbrli:pureiso4217:USDxbrli:sharesswmr:Customerxbrli:sharesswmr:Vehicleswmr:Segmentiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 10-Q

 

 

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2026

OR

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-43192

 

 

Swarmer, Inc

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

93-1378503

( State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

4515 Seton Center Pkwy #330

Austin, TX

78759

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (512) 305-3513

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.00001 per share

 

SWMR

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

☐

 

Accelerated filer

 

☐

Non-accelerated filer

 

☒

 

Smaller reporting company

 

☒

Emerging growth company

 

☒

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 10, 2026, the registrant had 19,402,274 shares of common stock, $0.00001 par value per share, outstanding.

 

 


Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are based on our management’s beliefs and assumptions and on information currently available to our management. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, business strategy, plans for our products, future research and development costs, regulatory approvals, timing and likelihood of success, as well as plans and objectives of management for future operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that are in some cases beyond our control and may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

In some cases, you can identify forward-looking statements by words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will,” “would,” or the negative of these words or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:

•
estimates of our addressable market, market growth, future revenue, key performance indicators, expenses, capital requirements and our needs for additional financing;
•
our ability to obtain funding for our operations;
•
our ability to retain the continued service of our key professionals and to identify, hire and retain additional qualified professionals;
•
the implementation of our business model, strategic plans for our business and technology;
•
the scope of protection we are able to establish and maintain for intellectual property rights covering our technology;
•
developments relating to our competitors and our industry;
•
legal and regulatory developments relating to artificial intelligence (“AI”) and unmanned systems;
•
the accuracy of our estimates regarding expenses, capital requirements and needs for additional financing and our ability to continue as a going concern;
•
our ability to obtain additional financing on acceptable terms;
•
our ability to complete the pending acquisition of LLC “JK Land Vehicles” (Ratel Robotics), to integrate its business and to realize the anticipated benefits of the acquisition;
•
our ability to enter into definitive agreements with Vectus Air Defense Systems LLC under our nonbinding memorandum of understanding, to establish manufacturing operations in Poland, and to obtain the required export control and other government approvals;
•
our financial performance; and
•
the ongoing military invasion by Russia in Ukraine and its impact on the continued deployment of our software products, AI systems and operational datasets.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in the “Risk Factors” sections of this Quarterly Report on Form 10-Q, our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026, filed with the Securities and Exchange Commission on May 14, 2026 and August 14, 2026, respectively, and the final prospectus for our initial public offering, dated as of March 16, 2026, and filed with the Securities and Exchange Commission, pursuant to Rule 424(b)(4) on March 17, 2026. Given these uncertainties, you should not place undue reliance on these forward-looking statements.

Forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Quarterly Report on Form 10-Q. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. You should read this Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect.

i


We do not use the ® or ™ symbol in each instance in which one of our trademarks appears in this report, but this should not be construed as any indication that we will not assert our rights thereto to the fullest extent under applicable law.

ii


Table of Contents

 

 

 

Page

 

 

 

PART I.

FINANCIAL INFORMATION

1

 

 

 

Item 1.

Financial Statements (Unaudited)

1

 

Condensed Consolidated Balance Sheets

1

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

2

 

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)

3

 

Condensed Consolidated Statements of Cash Flows

5

 

Notes to Unaudited Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

21

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

30

Item 4.

Controls and Procedures

30

 

 

 

PART II.

OTHER INFORMATION

33

 

 

 

Item 1.

Legal Proceedings

33

Item 1A.

Risk Factors

33

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

34

Item 3.

Defaults Upon Senior Securities

34

Item 4.

Mine Safety Disclosures

34

Item 5.

Other Information

34

Item 6.

Exhibits

36

Signatures

37

 

iii


PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

SWARMER, INC

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

September 30,
2026

 

 

December 31,
2025

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

37,281,357

 

 

$

9,283,566

 

Accounts receivable

 

 

108,509

 

 

 

—

 

UAV deployment program advance payment

 

 

1,845,000

 

 

 

—

 

Prepaid expenses and other current assets

 

 

1,071,539

 

 

 

115,473

 

Total current assets

 

 

40,306,405

 

 

 

9,399,039

 

Property and equipment, net

 

 

506,391

 

 

 

227,908

 

Operating lease right-of-use asset

 

 

83,528

 

 

 

131,184

 

Intangible assets

 

 

97,668

 

 

 

—

 

Deferred offering costs

 

 

—

 

 

 

471,719

 

Other assets

 

 

316,373

 

 

 

106,830

 

Total assets

 

$

41,310,365

 

 

$

10,336,680

 

Liabilities, convertible preferred stock and stockholders’ equity (deficit)

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

556,172

 

 

$

223,236

 

Accrued expenses and other current liabilities

 

 

2,148,644

 

 

 

680,782

 

Grant advance

 

 

179,108

 

 

 

189,200

 

Deferred revenue

 

 

130,250

 

 

 

23,272

 

Operating lease liability - current

 

 

74,850

 

 

 

70,703

 

Advances received under combined arrangement

 

 

793,092

 

 

 

—

 

Total current liabilities

 

 

3,882,116

 

 

 

1,187,193

 

Operating lease liability - non-current

 

 

19,680

 

 

 

76,273

 

Total liabilities

 

 

3,901,796

 

 

 

1,263,466

 

Convertible preferred stock, par value $0.00001 per share:

 

 

 

 

 

 

Series A preferred stock: no shares authorized, issued or outstanding as of September 30, 2026; 4,358,597 shares authorized and 3,661,083 shares issued and outstanding as of December 31, 2025

 

 

—

 

 

 

19,013,673

 

Commitments and contingencies (Note 10)

 

 

 

 

 

 

Stockholders’ equity (deficit)

 

 

 

 

 

 

Preferred stock, $0.00001 par value; 10,000,000 shares authorized and no shares issued and outstanding as of September 30, 2026; no shares authorized, issued or outstanding as of December 31, 2025

 

 

—

 

 

 

—

 

Common stock, $0.00001 par value; 200,000,000 and 25,000,000 shares authorized as of September 30, 2026 and December 31, 2025, respectively; 18,963,373 and 1,410,975 shares issued as of September 30, 2026 and December 31, 2025, respectively; and 18,728,211 and 911,255 shares outstanding as of September 30, 2026 and December 31, 2025, respectively

 

 

187

 

 

 

10

 

Additional paid-in capital

 

 

69,200,151

 

 

 

663,514

 

Accumulated other comprehensive income (loss)

 

 

(94,373

)

 

 

(4,900

)

Accumulated deficit

 

 

(31,697,396

)

 

 

(10,599,083

)

Total stockholders’ equity (deficit)

 

 

37,408,569

 

 

 

(9,940,459

)

Total liabilities, convertible preferred stock and stockholders’ equity (deficit)

 

$

41,310,365

 

 

$

10,336,680

 

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

1


SWARMER, INC

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenue

 

$

25,554

 

 

$

35,771

 

 

$

262,292

 

 

$

284,681

 

Cost of revenue

 

 

72,647

 

 

 

45,441

 

 

 

145,387

 

 

 

147,159

 

Gross margin

 

 

(47,093

)

 

 

(9,670

)

 

 

116,905

 

 

 

137,522

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

7,446,563

 

 

 

139,343

 

 

 

16,109,080

 

 

 

672,215

 

Research and development

 

 

1,979,116

 

 

 

641,686

 

 

 

5,270,730

 

 

 

1,741,140

 

Total operating expenses

 

 

9,425,679

 

 

 

781,029

 

 

 

21,379,810

 

 

 

2,413,355

 

Loss from operations

 

 

(9,472,772

)

 

 

(790,699

)

 

 

(21,262,905

)

 

 

(2,275,833

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of Simple Agreement for Future Equity ("SAFE") liability

 

 

—

 

 

 

(2,624,431

)

 

 

—

 

 

 

(3,493,431

)

Change in fair value of Equity Line of Credit ("ELOC") derivative

 

 

(40,385

)

 

 

—

 

 

 

(291,840

)

 

 

—

 

Other income

 

 

200,339

 

 

 

39,820

 

 

 

458,054

 

 

 

72,795

 

Loss before income taxes

 

 

(9,312,818

)

 

 

(3,375,310

)

 

 

(21,096,691

)

 

 

(5,696,469

)

Income tax expense

 

 

(1,622

)

 

 

—

 

 

 

(1,622

)

 

 

—

 

Net loss

 

$

(9,314,440

)

 

$

(3,375,310

)

 

$

(21,098,313

)

 

$

(5,696,469

)

Net loss per share of common stock, basic and diluted

 

$

(0.51

)

 

$

(0.91

)

 

$

(1.53

)

 

$

(1.77

)

Weighted-average shares of common stock outstanding, basic and diluted

 

 

18,119,504

 

 

 

3,699,499

 

 

 

13,782,434

 

 

 

3,216,345

 

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(289,875

)

 

 

(5,337

)

 

 

(89,473

)

 

 

9,407

 

Total comprehensive loss

 

$

(9,604,315

)

 

$

(3,380,647

)

 

$

(21,187,786

)

 

$

(5,687,062

)

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

2


SWARMER, INC

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

For the Three Months Ended September 30, 2026

 

 

 

Common Stock

 

 

Additional
Paid-in-

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (Loss)

 

 

Deficit

 

 

Total

 

Balance at June 30, 2026

 

 

11,284,769

 

 

$

113

 

 

$

53,397,926

 

 

$

195,502

 

 

$

(22,382,956

)

 

$

31,210,585

 

Issuance of common stock upon exercise of stock options

 

 

4,668,931

 

 

 

47

 

 

 

408,755

 

 

 

—

 

 

 

—

 

 

 

408,802

 

Cashless exercise of common stock warrants

 

 

2,121,947

 

 

 

21

 

 

 

(21

)

 

 

—

 

 

 

—

 

 

 

—

 

Issuance of common stock on vesting of restricted stock and restricted stock units

 

 

311,826

 

 

 

3

 

 

 

(3

)

 

 

—

 

 

 

—

 

 

 

—

 

Share-based compensation

 

 

—

 

 

 

—

 

 

 

1,717,041

 

 

 

—

 

 

 

—

 

 

 

1,717,041

 

Issuance of shares under ELOC

 

 

340,738

 

 

 

3

 

 

 

13,743,403

 

 

 

—

 

 

 

—

 

 

 

13,743,406

 

Reclassification of deferred financing costs to additional paid-in capital upon consummation of public offering

 

 

—

 

 

 

—

 

 

 

(66,950

)

 

 

—

 

 

 

—

 

 

 

(66,950

)

Foreign currency translation adjustments

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(289,875

)

 

 

—

 

 

 

(289,875

)

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(9,314,440

)

 

 

(9,314,440

)

Balance at September 30, 2026

 

 

18,728,211

 

 

$

187

 

 

$

69,200,151

 

 

$

(94,373

)

 

$

(31,697,396

)

 

$

37,408,569

 

 

For the Three Months Ended September 30, 2025

 

 

 

Series A Convertible Preferred Stock

 

 

Common Stock

 

 

Additional
Paid-in-

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (Loss)

 

 

Deficit

 

 

Total

 

Balance at June 30, 2025

 

 

—

 

 

$

—

 

 

 

734,883

 

 

$

8

 

 

$

29,693

 

 

$

14,135

 

 

$

(4,390,979

)

 

$

(4,347,143

)

Sale of Series A convertible preferred stock and common stock warrants, net of issuance costs

 

 

554,447

 

 

 

3,148,999

 

 

 

—

 

 

 

—

 

 

 

201,002

 

 

 

—

 

 

 

—

 

 

 

201,002

 

Conversion of SAFEs into Series A convertible preferred stock

 

 

1,727,478

 

 

 

7,488,431

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Issuance of common stock on vesting of restricted stock

 

 

—

 

 

 

—

 

 

 

88,186

 

 

 

1

 

 

 

(1

)

 

 

—

 

 

 

—

 

 

 

—

 

Share-based compensation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

17,873

 

 

 

—

 

 

 

—

 

 

 

17,873

 

Foreign currency translation adjustments

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(5,337

)

 

 

—

 

 

 

(5,337

)

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(3,375,310

)

 

 

(3,375,310

)

Balance at September 30, 2025

 

 

2,281,925

 

 

$

10,637,430

 

 

 

823,069

 

 

$

9

 

 

$

248,567

 

 

$

8,798

 

 

$

(7,766,289

)

 

$

(7,508,915

)

 

 

 

 

 

 

 

 

 

 

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

3


SWARMER, INC

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

For the Nine Months Ended September 30, 2026

 

 

 

Series A Convertible Preferred Stock

 

 

Common Stock

 

 

Additional
Paid-in-

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (Loss)

 

 

Deficit

 

 

Total

 

Balance at December 31, 2025

 

 

3,661,083

 

 

$

19,013,673

 

 

 

911,255

 

 

$

10

 

 

$

663,514

 

 

$

(4,900

)

 

$

(10,599,083

)

 

$

(9,940,459

)

Sale of Series A-1 convertible preferred stock

 

 

558,116

 

 

 

3,472,095

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Issuance of common stock and pre-funded warrants for conversion of Series A convertible preferred stock

 

 

(4,219,199

)

 

 

(22,485,768

)

 

 

6,137,634

 

 

 

61

 

 

 

22,485,707

 

 

 

—

 

 

 

—

 

 

 

22,485,768

 

Issuance of common stock under initial public offering, net of underwriters discounts

 

 

—

 

 

 

—

 

 

 

3,450,000

 

 

 

35

 

 

 

16,014,965

 

 

 

—

 

 

 

—

 

 

 

16,015,000

 

Issuance of shares under ELOC

 

 

—

 

 

 

—

 

 

 

654,734

 

 

 

6

 

 

 

27,521,500

 

 

 

—

 

 

 

—

 

 

 

27,521,506

 

Reclassification of deferred financing costs to additional paid-in capital upon consummation of public offering and sale of Series A convertible preferred stock

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,071,283

)

 

 

—

 

 

 

—

 

 

 

(1,071,283

)

Issuance of common stock upon exercise of stock options

 

 

—

 

 

 

—

 

 

 

4,880,578

 

 

 

49

 

 

 

408,754

 

 

 

—

 

 

 

—

 

 

 

408,803

 

Cashless exercise of common stock warrants

 

 

—

 

 

 

—

 

 

 

2,121,947

 

 

 

21

 

 

 

(21

)

 

 

—

 

 

 

—

 

 

 

—

 

Issuance of common stock on vesting of restricted stock and restricted stock units

 

 

—

 

 

 

—

 

 

 

572,063

 

 

 

5

 

 

 

(5

)

 

 

—

 

 

 

—

 

 

 

—

 

Share-based compensation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

3,177,020

 

 

 

—

 

 

 

—

 

 

 

3,177,020

 

Foreign currency translation adjustments

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(89,473

)

 

 

—

 

 

 

(89,473

)

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(21,098,313

)

 

 

(21,098,313

)

Balance at September 30, 2026

 

 

—

 

 

$

—

 

 

 

18,728,211

 

 

$

187

 

 

$

69,200,151

 

 

$

(94,373

)

 

$

(31,697,396

)

 

$

37,408,569

 

 

 

For the Nine Months Ended September 30, 2025

 

 

 

Series A Convertible Preferred Stock

 

 

Common Stock

 

 

Additional
Paid-in-

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (Loss)

 

 

Deficit

 

 

Total

 

Balance at December 31, 2024

 

 

—

 

 

$

—

 

 

 

558,511

 

 

$

6

 

 

$

1,207

 

 

$

(609

)

 

$

(2,069,820

)

 

$

(2,069,216

)

Sale of Series A convertible preferred stock and common stock warrants, net of issuance costs

 

 

554,447

 

 

 

3,148,999

 

 

 

—

 

 

 

—

 

 

 

201,002

 

 

 

—

 

 

 

—

 

 

 

201,002

 

Conversion of SAFEs into Series A convertible preferred stock

 

 

1,727,478

 

 

 

7,488,431

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Issuance of common stock on vesting of restricted stock

 

 

—

 

 

 

—

 

 

 

264,558

 

 

 

3

 

 

 

(3

)

 

 

—

 

 

 

—

 

 

 

—

 

Share-based compensation

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

46,361

 

 

 

—

 

 

 

—

 

 

 

46,361

 

Foreign currency translation adjustments

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

9,407

 

 

 

—

 

 

 

9,407

 

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(5,696,469

)

 

 

(5,696,469

)

Balance at September 30, 2025

 

 

2,281,925

 

 

$

10,637,430

 

 

 

823,069

 

 

$

9

 

 

$

248,567

 

 

$

8,798

 

 

$

(7,766,289

)

 

$

(7,508,915

)

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

4


SWARMER, INC

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Nine Months Ended September 30,

 

Operating activities:

 

2026

 

 

2025

 

Net loss

 

$

(21,098,313

)

 

$

(5,696,469

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

Depreciation expense

 

 

173,352

 

 

 

—

 

Amortization of ROU asset

 

 

47,656

 

 

 

—

 

Change in fair value of ELOC derivative

 

 

291,840

 

 

 

—

 

Change in fair value of SAFE liability

 

 

—

 

 

 

3,493,431

 

Share-based compensation expense

 

 

3,177,020

 

 

 

46,361

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(108,509

)

 

 

—

 

Unbilled revenue

 

 

—

 

 

 

12,417

 

UAV deployment program advance payment

 

 

(1,845,000

)

 

 

—

 

Prepaid expenses and other current assets

 

 

(566,573

)

 

 

(88,934

)

Other assets

 

 

(189,919

)

 

 

(20,806

)

Accounts payable

 

 

333,004

 

 

 

(6,106

)

Accrued expenses and other liabilities

 

 

1,467,868

 

 

 

15,835

 

Grant advance

 

 

—

 

 

 

144,257

 

Deferred revenue

 

 

107,912

 

 

 

49,398

 

Advances received under combined arrangement

 

 

793,092

 

 

 

—

 

Operating lease liability

 

 

(52,446

)

 

 

—

 

Net cash used in operating activities

 

 

(17,469,016

)

 

 

(2,050,616

)

Investing activities:

 

 

 

 

 

 

Purchase of property and equipment

 

 

(458,707

)

 

 

(40,011

)

Purchase of intangible assets

 

 

(97,668

)

 

 

—

 

Investment in equity method investee

 

 

(20,000

)

 

 

—

 

Cash used in investing activities

 

 

(576,375

)

 

 

(40,011

)

Financing activities:

 

 

 

 

 

 

Proceeds from initial public offering, net of underwriting discounts

 

 

16,015,000

 

 

 

—

 

Proceeds from ELOC

 

 

27,229,669

 

 

 

—

 

Proceeds from sale of Series A-1 convertible preferred stock

 

 

3,472,095

 

 

 

3,350,000

 

Proceeds from exercise of stock options

 

 

408,803

 

 

 

—

 

Proceeds from issuance of SAFEs

 

 

—

 

 

 

30,000

 

Payment of financing costs

 

 

(993,215

)

 

 

—

 

Cash provided by financing activities

 

 

46,132,352

 

 

 

3,380,000

 

Effect of exchange rates on cash and cash equivalents

 

 

(89,170

)

 

 

14,609

 

Net increase in cash and cash equivalents

 

 

27,997,791

 

 

 

1,303,982

 

Cash and cash equivalents at the beginning of the period

 

 

9,283,566

 

 

 

2,081,086

 

Cash and cash equivalents at the end of the period

 

$

37,281,357

 

 

$

3,385,068

 

Supplemental non-cash investing and financing activities:

 

 

 

 

 

 

Conversion of Series A Preferred Stock into Common Stock

 

$

22,485,768

 

 

$

—

 

Issuance of Series A convertible preferred stock upon conversion of SAFEs

 

$

—

 

 

$

7,488,431

 

 

The accompanying footnotes are an integral part of these unaudited condensed consolidated financial statements.

5


SWARMER, INC

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.
Nature of Operations

Swarmer, Inc (“Swarmer,” the “Company,” “we,” “us,” and “our”), a Delaware corporation, together with its wholly owned subsidiaries, is a provider of autonomous drone swarm software and artificial intelligence solutions, specializing in vendor-agnostic technologies that address critical operational challenges faced by modern military forces. The Company’s primary customer base consists of drone manufacturers who license Swarmer’s software for integration with their hardware platforms. Swarmer delivers software platforms and AI systems that enable military organizations to deploy and coordinate large-scale unmanned systems operations without requiring proportional increases in trained operators. The Company’s primary mission areas include autonomous swarm coordination, multi-domain unmanned systems integration, AI-powered collaborative autonomy, and command and control software for distributed robotic operations.

During January 2026, the Company sold 558,116 shares of Series A-1 convertible preferred stock at a price of $6.2711 per share for gross proceeds of approximately $3.5 million.

On February 18, 2026, the Company’s board of directors approved a 1.8813-for-1 forward stock split of the Company’s issued and outstanding common stock. The forward stock split became effective on February 18, 2026. All common share amounts, per share amounts, exercise prices, conversion ratios and other share-related information presented in these condensed consolidated financial statements and accompanying notes have been retroactively adjusted to reflect the stock split for all periods presented.

On March 18, 2026, the Company completed its initial public offering (“IPO”) of 3,450,000 shares of common stock at a public offering price of $5.00 per share. Net proceeds to the Company, after deducting underwriting discounts, commissions and offering expenses, were approximately $14.9 million. In connection with the IPO, all outstanding shares of the Company’s Series A convertible preferred stock automatically converted into an aggregate of (i) 6,137,634 shares of common stock and (ii) pre-funded warrants to purchase up to 1,799,970 shares of common stock.

2.
Going Concern and Liquidity

In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. The Company has incurred recurring losses and negative cash flows from operations since inception, and, as of September 30, 2026, the Company had cash and cash equivalents of $37.3 million and an accumulated deficit of $31.7 million. In January 2026, the Company sold 558,116 shares of Series A-1 convertible preferred stock at a price of $6.2711 per share for gross proceeds of approximately $3.5 million. On March 18, 2026, the Company completed its IPO, selling 3,450,000 shares of common stock at a price of $5.00 per share for gross proceeds of approximately $17.3 million. From the commencement of its equity line of credit (“ELOC”) with Lucid Capital Markets, LLC (“Lucid”) on June 15, 2026 through September 30, 2026, the Company sold 654,734 shares of common stock under the ELOC for aggregate gross proceeds of approximately $27.2 million. The Company’s evaluation includes the cash consideration payable at the closing of the pending acquisition of Ratel Robotics, the contingent cash consideration that may become payable in 2027, Ratel’s operations following the closing, and the $0.5 million cash consideration paid at the closing of the Vataga acquisition on November 10, 2026, as described in Notes 10 and 16.

Since its inception in May 2023, the Company has funded its operations through the sale of simple agreements for future equity (“SAFEs”), the sale of Series A convertible preferred stock, software license sales, its IPO and the issuance of common stock under its ELOC. As the Company continues to pursue its business plan, it may seek to finance its operations through additional equity offerings, debt financings, or other capital sources. However, there can be no assurance that any additional financing or strategic arrangements will be available to the Company on acceptable terms, if at all. If events or circumstances occur such that the Company does not obtain additional funding, it may be necessary to significantly reduce its scope of operations to reduce the current rate of spending.

Based on the Company’s current operating plan, expected operating expenditures, including the cash consideration payable at the closing of the pending Ratel acquisition and the contingent cash consideration that may become payable in 2027, and existing cash and cash equivalents, management identified conditions that raised substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. Management’s operating plan includes sales of common stock under the ELOC and the use of cash generated by Ratel’s operations following the closing, including through distributions from Ratel to the Company. ELOC proceeds depend on the market price and trading volume of the Company’s common stock, which are outside the Company’s control. Ratel’s cash flows depend in part on Ratel obtaining new orders, including customer prepayments, that are not yet under contract, and on Ratel’s continued operations in Ukraine during the ongoing war, and cash

6


held by Ratel is located in Ukraine and is subject to the currency controls of the National Bank of Ukraine and to tax on distributions, which may limit or delay its transfer to the Company. Because of these uncertainties, the Company issued a promissory note on November 16, 2026 to an institutional investor (the “Investor”) as an additional measure. The note provides the Company with a committed facility to borrow up to $10.0 million (the “Promissory Note”). Advances bear interest at 7.00% per year, and all amounts outstanding are due on January 16, 2028. As of the date the condensed consolidated financial statements were issued, no amounts had been borrowed under the Promissory Note. If necessary, the Company may also reduce the scope of its operations to reduce its rate of spending. Management has concluded that its existing cash and cash equivalents, together with the borrowings available under the Promissory Note, will be sufficient to fund the Company’s obligations for at least twelve months from the date the condensed consolidated financial statements are issued, without relying on proceeds from the ELOC or distributions from Ratel. Because the Company may borrow under the Promissory Note if needed, management has concluded that substantial doubt about the Company’s ability to continue as a going concern has been alleviated. See Note 16.

 

3.
Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of Swarmer, Inc and its wholly owned subsidiaries, Autonomous Robotics Systems LLC ("ARS"), Swarmer Estonia OÜ ("Estonia") and Swarmer Poland sp. z o.o. ("Poland"). All significant intercompany balances and transactions have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) applicable to Quarterly Reports on Form 10-Q. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete annual financial statements.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the interim periods presented. Interim results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the full fiscal year ending December 31, 2026 or any future period.

The December 31, 2025 Condensed Consolidated Balance Sheet included herein was derived from the audited financial statements as of that date but does not include all disclosures required by U.S. GAAP for annual financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s final prospectus filed with the SEC pursuant to Rule 424(b)(4) on March 17, 2026.

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Significant estimates include the fair value of the ELOC derivative and, for comparative periods, the SAFE liability; the standalone selling prices of performance obligations; share-based compensation; the valuation allowance recorded against deferred tax assets; and the useful lives of long-lived and intangible assets.

Foreign Currency Translation

The condensed consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. The functional currency of ARS is the Ukrainian hryvnia, and the functional currency of Estonia and Poland is the U.S. dollar. Revenue and expenses of ARS have been translated into U.S. dollars at average exchange rates prevailing during the period. Monetary assets and liabilities of Estonia and Poland denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars, with remeasurement gains and losses recognized in other income (expense).

Assets and liabilities have been translated at the rates of exchange on the balance sheet dates and equity accounts at their historic rates. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss).

7


Concentration of Credit Risk

Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, which at times, may exceed the Federal Deposit Insurance Corporation ("FDIC") coverage limit of $250,000. The Company holds cash at financial institutions that the Company believes are good credit quality financial institutions and limits the amount of credit exposure with any one bank and conducts ongoing evaluations of the creditworthiness of the banks with which it does business.

For the three and nine months ended September 30, 2026, the SkyKnight counterparty group accounted for 100% and approximately 91%, respectively, of the Company’s revenue, and one other customer accounted for substantially all of the remainder of revenue for the nine months ended September 30, 2026. For the three and nine months ended September 30, 2025, one customer accounted for substantially all of the Company’s revenue. The Company operates as a single reportable segment, and all of the revenue described above is reported in that segment.

As of September 30, 2026, a member of the SkyKnight counterparty group accounted for all of the Company’s accounts receivable. The Company had no customer accounts receivable as of December 31, 2025.

The Company’s revenue is concentrated among a small number of customers. The loss of, or a significant reduction in orders from, any such customer could have a material adverse effect on the Company’s results of operations.

Intangible Assets

Intangible assets acquired individually are recorded at cost, including directly attributable acquisition costs. Intangible assets with indefinite useful lives are not amortized and are tested for impairment at least annually, and more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired.

Income Taxes

The Company computes its interim income tax provision by applying its estimated annual effective tax rate to year-to-date pre-tax loss, adjusted for discrete items arising in the period. The Company recorded income tax expense of $1,622 for each of the three and nine months ended September 30, 2026, related to Estonia, and no provision for income taxes for the three and nine months ended September 30, 2025. The Company’s effective tax rate for each period was approximately 0%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the full valuation allowances recorded against deferred tax assets generated in the United States, Estonia, Poland and Ukraine, as the Company has concluded, based on its history of operating losses, that it is more likely than not that these deferred tax assets will not be realized.

Recently Adopted Accounting Pronouncements

In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU 2025-05, "Measurement of Credit Losses for Accounts Receivable and Contract Assets", which amends ASC 326 and provides a practical expedient for entities when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under ASC 606. The practical expedient permits an entity to assume that current conditions as of the balance sheet date do not change over the remaining life of such financial assets, thereby reducing the complexity associated with developing reasonable and supportable forecasts. The update also permits entities that are not public business entities to elect an accounting policy to consider subsequent collection activity when estimating expected credit losses; this provision is not applicable to the Company. The amendments are effective for annual reporting periods beginning after December 15, 2025, including interim periods within those annual reporting periods, with early adoption permitted. The Company adopted this ASU on January 1, 2026, prospectively and the impact was not material to the unaudited condensed consolidated financial statements.

 

Recently Issued Accounting Pronouncements Not Yet Adopted

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses. ASU 2024-03 requires additional disclosure of specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. The requirements will be applied prospectively with the option for retrospective application. The Company is currently evaluating the impact that the adoption of ASU 2024-03 will have on its consolidated financial statements and disclosures.

In May 2025, the FASB issued ASU 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity. The ASU requires an entity to apply the factors in ASC 805 used to identify the accounting acquirer when the legal acquiree in a business combination effected primarily by exchanging equity

8


interests is a variable interest entity that meets the definition of a business. ASU 2025-03 is effective for the Company on January 1, 2027, with early adoption permitted, and is applied prospectively to acquisition transactions that occur after adoption. The Vataga acquisition, which closed on November 10, 2026, and the pending Ratel acquisition, which is expected to close before the effective date, will not be affected. The effect of ASU 2025-03 on future acquisitions will depend on the facts and terms of each transaction.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 removes all references to software development project stages, so that the guidance applies regardless of the development method used, including agile methods, and clarifies when it is probable that a software project will be completed. ASU 2025-06 is effective for annual periods beginning after December 15, 2027, including interim periods within those annual periods, with early adoption permitted, and may be applied prospectively, retrospectively or using a modified transition approach. The Company is currently evaluating the impact that the adoption of ASU 2025-06 will have on its consolidated financial statements and disclosures.

In September 2025, the FASB issued ASU 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract. ASU 2025-07 excludes from derivative accounting certain non-exchange-traded contracts with underlyings based on the operations or activities specific to one of the parties to the contract, and clarifies the accounting for share-based noncash consideration received from a customer. ASU 2025-07 is effective for annual reporting periods beginning after December 15, 2026, including interim periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact that the adoption of ASU 2025-07 will have on its consolidated financial statements.

 

4.
Intangible Assets

During May 2026, the Company acquired the internet domain name swarmer.com for use as its primary corporate domain for total consideration of $97,668, consisting of a purchase price of $72,000 and directly attributable acquisition costs of $25,668, including escrow and broker fees. The acquisition was accounted for as an asset acquisition, and the domain name was recognized as a separately acquired intangible asset in accordance with ASC 350. The Company has determined that the domain name has an indefinite useful life, as domain registrations are renewable indefinitely at nominal cost within the Company's control and no legal, regulatory, contractual, competitive, or economic factors limit the period over which the domain is expected to contribute to the Company's cash flows. Accordingly, the domain name is not amortized and is tested for impairment at least annually, and more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired. Periodic registration renewal fees are expensed as incurred. As of September 30, 2026, the carrying amount of the domain name was $0.1 million, and no impairment has been recognized.

5.
Simple Agreement for Future Equity (SAFE)

SAFEs represent financing instruments with characteristics of both debt and equity. The Company accounts for its SAFEs in accordance with ASC 480, Distinguishing Liabilities from Equity. Through September 22, 2025, the Company had outstanding SAFEs that met the definition of a liability, as the instruments included terms that affected conversion based on the next round of financing and provided for potential cash settlement upon the occurrence of certain liquidity events. Accordingly, the SAFEs were recorded as liabilities at fair value.

The SAFE liability was remeasured at each balance sheet date until the occurrence of a triggering event, including an equity financing, change in control, or dissolution, with changes in fair value recognized in the consolidated statements of operations and comprehensive loss. The fair value estimate incorporated significant unobservable inputs and was classified as a Level 3 measurement within the fair value hierarchy. The valuation considered probability-weighted outcomes under various scenarios, including: (i) an equity financing in which the SAFEs would convert into convertible preferred stock; (ii) a liquidity event in which SAFE holders would receive the greater of the cash-out amount or the amount payable based on the number of shares of common stock equal to the purchase amount divided by the liquidity price; and (iii) a dissolution event in which SAFE holders would receive a portion of the remaining cash.

The Company recognized the change in fair value of the SAFE liability in earnings; for the three and nine months ended September 30, 2025, this resulted in a net loss of approximately $2.6 million and $3.5 million, respectively, presented within other income (expense) as change in fair value of SAFE liability. At September 22, 2025, the date of the conversion, the fair value of the SAFEs was equal to the fair value of the Series A-2 through Series A-6 convertible preferred stock into which they converted. The fair value of that preferred stock was estimated using a hybrid method that combines a Probability-Weighted Expected Return Method and an Option-Pricing Model, using the following inputs:

 

9


Multiple scenarios expected term (in years)

 

2.80

 

Probability of initial public offering

 

40.0

%

Probability of stay private

 

60.0

%

Equity volatility

 

59.0

%

Risk-free rate

 

3.5

%

 

On September 22, 2025, in connection with the initial closing of the Series A-1 convertible preferred stock financing, all outstanding SAFEs automatically converted into an aggregate of 1,727,478 shares of Series A-2 through Series A-6 convertible preferred stock in accordance with their terms. No SAFEs were outstanding as of September 30, 2026.

The following table summarizes the changes in the fair value of the SAFE liability for the nine months ended September 30, 2025:

 

Balance at December 31, 2024

$

3,965,000

 

Issuance of SAFEs

 

30,000

 

Change in fair value recognized through earnings

 

3,493,431

 

Conversion into Series A-2 through Series A-6 convertible preferred stock

 

(7,488,431

)

Balance at September 30, 2025

$

—

 

 

 

The Company did not incur any issuance costs related to SAFEs during the three and nine months ended September 30, 2026 or the year ended December 31, 2025.

6.
Equity Line of Credit (ELOC)

As described in Note 12, on June 10, 2026, the Company entered into the common stock purchase agreement (the “Purchase Agreement”) with Lucid establishing the ELOC, under which the Company may, in its sole discretion, sell up to 3,000,000 newly issued shares of its common stock to Lucid from time to time over a 24-month period, subject to the conditions and limitations set forth in the Purchase Agreement. From the facility’s commencement on June 15, 2026 through September 30, 2026, the Company sold 654,734 shares of common stock under the facility for aggregate gross proceeds of approximately $27.2 million, including 280,516 shares sold during the three months ended September 30, 2026 for aggregate gross proceeds of approximately $11.0 million. All shares sold under the facility had been issued, and all proceeds had been received, as of September 30, 2026. The terms of the facility and the related derivative accounting, including the fair value measurement of the ELOC derivative, are described in Note 12.

Fair Value of ELOC Derivative

The ELOC derivative is measured at fair value on a recurring basis and is classified within Level 3 of the fair value hierarchy, as its measurement reflects significant unobservable inputs, including the expected timing and volume of future sales under the facility. No draws were priced and unsettled at September 30, 2026, and accordingly no derivative asset or liability was recorded at that date. No comparable instruments were outstanding at December 31, 2025. The following table summarizes the changes in the fair value of the ELOC derivative for the nine months ended September 30, 2026:

 

Balance at December 31, 2025

$

—

 

Loss on change in fair value recognized through earnings

 

(291,840

)

Amounts settled through the issuance of common stock

 

291,840

 

Balance at September 30, 2026

$

—

 

 

10


7.
Unmanned Aerial Vehicle (UAV) Deployment Program Advance Payment

During June 2026, the Company made an advance payment of $2.2 million under a Procurement and Deployment Service Agreement (“Procurement Agreement”) entered into in connection with the Ukraine UAV Deployment Program described in Note 10 below. Under the arrangement, Progress TRW S.R.O. (“Progress”), which acts as facilitator and is a member of the counterparty group to the combined arrangement described in Note 9, procures unmanned aerial vehicles and arranges for the integration of the Company’s proprietary software and the deployment of the vehicles for use by designated military units. The advance payment has been recorded as a UAV deployment program advance payment, presented separately on the unaudited Condensed Consolidated Balance Sheet, and forms part of the combined arrangement described in Note 9. The advance is carried at the $1.8 million supported fair value of the vehicles to be procured; the $0.4 million paid in excess of that fair value was accounted for as consideration payable to a customer and applied against the contract liability, as described in Note 9. As of September 30, 2026, the balance related to this program was $1.8 million.

8.
Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of:

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Liability under D&O insurance premium financing

 

$

178,441

 

 

$

—

 

Consulting and professional fees

 

 

1,237,347

 

 

 

635,678

 

Compensation

 

 

695,131

 

 

 

13,272

 

Other

 

 

37,725

 

 

 

31,832

 

 

$

2,148,644

 

 

$

680,782

 

 

11


9.
Advances Received Under Combined Arrangement

During the second quarter of 2026, the Company entered into a series of interrelated agreements associated with the SkyKnight drone program. The agreements were negotiated and executed contemporaneously with the same counterparty group and were economically linked and mutually dependent. Accordingly, the Company evaluated the agreements collectively and determined that they represent a single combined arrangement for accounting purposes. As part of the overall arrangement, the Company entered into two software licensing agreements: (i) a Master Supplier Agreement with Meta Bureau LLC, originally executed on May 11, 2026 and amended and restated on June 25, 2026, and (ii) a Master Supplier Agreement with Progress TRW S.R.O. Collectively, these agreements provide for licensing of the Company's software for aggregate contractual consideration of $3.9 million. During June 2026, the Company invoiced $1.5 million under these agreements, of which $1.4 million had been collected as of September 30, 2026. The remaining $67,500 is recorded in accounts receivable. In connection with the same overall arrangement, the Company also entered into two purchase agreements with Progress TRW S.R.O., each dated June 25, 2026, pursuant to which the Company agreed to pay aggregate consideration of $4.9 million. This amount comprises (i) $2.5 million for the procurement and deployment of 82 unmanned aerial vehicles ("UAVs") integrated with the Company's software and (ii) $2.4 million for platform integration, operating system and market development, and marketing services. Of the $2.5 million attributable to the UAVs, $2.2 million was paid in June 2026 as an advance, with the remaining $0.3 million payable upon delivery. The UAV deployments are intended to facilitate field testing and evaluation of the Company's software platform under operational conditions.

Because the software licensing agreements and purchase agreements were negotiated with the same counterparty group, in contemplation of one another, and in furtherance of a single commercial objective, the Company concluded that the agreements should be accounted for as a combined arrangement. Accordingly, the amounts payable under the purchase agreements were evaluated under the guidance for consideration payable to a customer in ASC 606. The Company concluded that the UAVs represent distinct goods for which fair value could be reasonably estimated based on available market data. Based on its valuation analysis, the Company determined that the aggregate supported fair value of the UAVs was approximately $1.8 million. The Company was unable to substantiate the fair value of the platform integration, operating system and market development, and marketing services using observable market evidence or other sufficient support. In addition, the portion of the UAV advance payment in excess of the supported fair value of the UAVs was accounted for as consideration payable to a customer. Accordingly, amounts associated with such services, together with amounts paid in excess of the supported fair value of the UAVs, were accounted for as consideration payable to a customer and reduced revenue recognized under the combined arrangement.

During the nine months ended September 30, 2026, the Company recognized revenue for software licenses delivered under the combined arrangement and recorded deferred revenue related to future support obligations. During the three months ended September 30, 2026, the Company recognized $25,554 of support revenue under the Master Supplier Agreement with Progress TRW S.R.O., which is recognized ratably over the 12-month support period that began in July 2026. Amounts invoiced in excess of revenue recognized and deferred revenue recorded are presented as advances received under combined arrangement on the unaudited Condensed Consolidated Balance Sheet as of September 30, 2026.

The Company paid an aggregate advance of $2.2 million under the purchase agreements during June 2026. Of this amount, $1.8 million, representing the supported fair value of the UAVs, is presented as UAV deployment program advance payment on the unaudited Condensed Consolidated Balance Sheet as of September 30, 2026. The remaining $0.4 million was accounted for as consideration payable to a customer, which reduces the transaction price of the combined arrangement, and was applied against the contract liability presented as advances received under combined arrangement. The $1.8 million advance payment attributable to the UAVs will be recognized as expense as the related UAVs are deployed. No UAVs had been deployed as of September 30, 2026; accordingly, no expense related to the UAV deployment program was recognized during the period.

 

10.
Commitments and Contingencies

In the ordinary course of business, the Company may be subject to certain other legal actions and claims, which may arise from time to time. The Company is not aware of any such pending legal or other proceedings that are reasonably likely to have a material impact on the Company. Notwithstanding, legal proceedings are subject to inherent uncertainties, and an unfavorable outcome could include monetary damages, and excessive verdicts can result from litigation, and as such, could result in a material adverse impact on the Company’s business, financial position, results of operations, and/or cash flows. Additionally, the Company may in the future incur judgments or enter into settlements of claims which may have a material adverse impact on the Company’s business, financial position, results of operations and/or cash flows.

 

 

12


Ukraine UAV Deployment Program

On June 25, 2026, the Company entered into two agreements with Progress, a facilitator organized in the Czech Republic and a member of the counterparty group to the combined arrangement described in Note 9, in connection with a program to procure, deploy, and integrate the Company's proprietary software onto unmanned aerial vehicles for use by designated military units of the Armed Forces of Ukraine:

(1)
A Procurement Agreement, under which the facilitator agreed to procure 82 unmanned aerial vehicles, together with related ground stations and peripheral equipment, and to arrange their deployment to designated military units, for a total service fee of $2.5 million.
(2)
An Integration and Marketing Service Agreement (“Integration Agreement”), under which the facilitator agreed to procure integration of the Company's proprietary software platform onto the 82 vehicles procured under the agreement described above, to facilitate integration of the Company's separate proprietary operating system software onto no fewer than 100 additional vehicles, and to produce co-branded marketing materials, for a total service fee of $2.4 million.

The aggregate contractual commitment under the two agreements is $4.9 million. As of September 30, 2026, the Company had paid $2.2 million, representing the advance payment installment due under the Procurement Agreement. The remaining $0.3 million balance under the Procurement Agreement becomes payable upon the Company's receipt of documentation evidencing deployment of the vehicles to the designated military units and delivery of the related co-branded marketing materials.

Each agreement is subject to termination and pro-rata refund provisions if the underlying services are not completed by specified milestone dates, and disputes are subject to binding arbitration administered by the SCC Arbitration Institute, seated in Stockholm, Sweden, with the substantive law of England and Wales governing. The $2.4 million payable under the Integration Agreement had not been invoiced as of September 30, 2026. These agreements form part of the combined arrangement described in Note 9. Consistent with the accounting described in Note 9, the remaining payments under these agreements, when made, will be applied against the recorded contract liability.

Pending Acquisition of Ratel Robotics

On September 9, 2026, the Company entered into a purchase agreement to acquire 100% of the equity interests in LLC “JK Land Vehicles,” a Ukrainian manufacturer of unmanned ground vehicles (“UGVs”) doing business as Ratel Robotics (“Ratel”) (the “Acquisition”). The consideration payable at closing consists of $7.2 million in cash, subject to adjustment for Ratel’s cash, indebtedness and net working capital, and 1,064,942 shares of the Company’s common stock, and the sellers may earn up to an additional $7.2 million in cash upon the achievement of revenue and operating income targets for fiscal year 2026 and up to an additional 4,422,125 shares of common stock upon the achievement of such targets for fiscal years 2026 through 2028. The Company will also pay $0.8 million in cash and grant 118,326 fully vested restricted stock units to Ratel employees at closing, and up to the same amounts if the fiscal year 2026 targets are achieved. Completion of the Acquisition is subject to customary closing conditions, including approval by the Company’s stockholders of the share issuance pursuant to Nasdaq Listing Rule 5635(a), which was obtained at a special meeting of stockholders held on November 2, 2026. Either party may terminate the purchase agreement, subject to certain exceptions, if the Acquisition has not been completed by January 7, 2027. As of September 30, 2026, the Acquisition had not closed. See Note 16.

Memorandum of Understanding with Vectus

On September 23, 2026, the Company entered into a nonbinding memorandum of understanding with Vectus Air Defense Systems LLC (“Vectus”) to manufacture, sell and deploy mobile air defense systems, subject to the negotiation of definitive agreements. As of September 30, 2026, no definitive agreements had been entered into and no transactions had occurred under the memorandum of understanding. Separately, in August 2026, the Company acquired a 20% interest in Vectus for $20,000, which is accounted for under the equity method and included in other assets. Erik Prince, the Non-Executive Chairman of the Company’s Board of Directors, is the Manager of Vectus.

 

13


Operating Lease

In October 2025, the Company entered into a 26-month operating lease agreement for office space (the “Operating Lease”) in Austin, Texas. As of September 30, 2026, the Company maintains a security deposit in the amount of $21,000 within other assets in the accompanying condensed consolidated balance sheets. Total lease expense for the Operating Lease in the condensed consolidated statements of operations and comprehensive loss was $17,208 and $51,623, respectively, for the three and nine months ended September 30, 2026.

The maturity of the Company’s operating lease liability as of September 30, 2026 was as follows:

 

 

 

Operating leases

 

2026

 

$

18,993

 

2027

 

 

77,860

 

Total lease payments

 

 

96,853

 

Less: present value adjustment

 

 

(2,323

)

Total lease liabilities

 

$

94,530

 

 

At September 30, 2026, the remaining lease term was 1.25 years and the discount rate was 4.50%.

In November 2025, the Company entered into an agreement for office space in Poland, which may be terminated at any time with 90-day notice. Rent expense related to this agreement was de minimis for the three and nine months ended September 30, 2026.

11.
Revenue

The following table summarizes revenue recognized for each respective period, disaggregated by timing of recognition (point-in-time versus over-time) and by type of performance obligation:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Performance obligations satisfied at point in time

 

$

—

 

 

$

165

 

 

$

214,243

 

 

$

176,544

 

Performance obligations satisfied over time

 

 

25,554

 

 

 

35,606

 

 

 

48,049

 

 

 

108,137

 

Total

 

$

25,554

 

 

$

35,771

 

 

$

262,292

 

 

$

284,681

 

 

Substantially all of the Company’s revenue for the three and nine months ended September 30, 2026 and 2025 was derived in Europe.

Contract liabilities consist of amounts received prior to satisfying the revenue recognition criteria, which are recorded as deferred revenue in the Company’s consolidated balance sheets.

The following table summarizes the changes in deferred revenue:

 

 

 

Nine Months Ended September 30,

 

 

 

 

2026

 

 

2025

 

 

Balance, beginning of period

 

$

23,272

 

 

$

—

 

 

Deferral of revenue

 

 

369,270

 

 

 

334,408

 

 

Recognition of unearned revenue

 

 

(262,292

)

 

 

(284,681

)

 

Balance, end of period

 

$

130,250

 

 

$

49,727

 

 

 

14


12.
Stockholders’ Equity

Preferred Stock Financing and Conversion

From September through December 2025, the Company issued and sold an aggregate of 1,933,605 shares of its Series A-1 convertible preferred stock at a price of $6.2711 per share for net proceeds of approximately $12.0 million, after deducting issuance costs of approximately $0.1 million. In connection with these sales, the Company issued warrants to purchase 2,999,950 shares of common stock to investors based on their investment amounts (see “Common Stock Purchase Warrants” below). The Company determined that the warrants were freestanding, equity-classified instruments and allocated the proceeds from the sales between the Series A-1 convertible preferred stock and the warrants based on their relative fair values. The fair value of the warrants was determined using a Black-Scholes option-pricing model.

Concurrent with the initial closing of the Series A-1 financing on September 22, 2025, all outstanding SAFEs automatically converted into an aggregate of 1,727,478 shares of Series A-2 through Series A-6 convertible preferred stock based on their contractual valuation caps or conversion prices. Because the SAFEs were remeasured to fair value immediately prior to conversion, the $7.5 million carrying value of the SAFE liability was reclassified to convertible preferred stock and no gain or loss was recognized on conversion.

In January 2026, the Company sold an additional 558,116 shares of Series A-1 convertible preferred stock at a price of $6.2711 per share for gross proceeds of approximately $3.5 million.

Immediately prior to the closing of the Company’s IPO on March 18, 2026, all outstanding shares of Series A convertible preferred stock automatically converted into either shares of common stock or pre-funded warrants exercisable for shares of common stock in accordance with the terms of the Company’s then-existing amended and restated certificate of incorporation. A total of 4,219,199 shares of Series A convertible preferred stock, consisting of 2,491,721 shares of Series A-1 and 1,727,478 shares of Series A-2 through Series A-6, were outstanding immediately prior to conversion, representing a carrying value of approximately $22.5 million.

Upon conversion, holders received an aggregate of 6,137,634 shares of common stock. In lieu of receiving common stock, one investor elected to receive a pre-funded warrant exercisable for 1,799,970 shares of common stock with a nominal exercise price.

Following the completion of the IPO, no shares of Series A convertible preferred stock remained issued or outstanding.

Initial Public Offering

On March 18, 2026, the Company completed its IPO of 3,450,000 shares of common stock, which included the full exercise of the underwriters’ over-allotment option, at a public offering price of $5.00 per share. The Company received gross proceeds of approximately $17.3 million and net proceeds of approximately $14.9 million after deducting underwriting discounts and commissions and other offering costs of approximately $2.4 million.

Equity Line of Credit

On June 10, 2026, the Company entered into the Purchase Agreement with Lucid, establishing an ELOC. Under the Purchase Agreement, the Company has the right, but not the obligation, in its sole discretion, to sell up to 3,000,000 newly issued shares of its common stock (representing up to approximately $181.0 million in aggregate gross proceeds based on the $60.32 closing price on June 9, 2026, of which approximately $27.2 million had been received through September 30, 2026) to Lucid from time to time over a 24-month period, subject to the conditions and limitations set forth in the Purchase Agreement. The Company controls the timing and amount of any sales and is under no obligation to sell any shares. Shares sold are priced at 98% of the volume-weighted average price of the common stock determined as provided in the Purchase Agreement (a 2% discount). Sales are subject to a 4.99% beneficial ownership limitation and, absent stockholder approval, to an aggregate limit of 2,240,930 shares (the “Exchange Cap”), representing approximately 19.99% of the shares of common stock outstanding at the time of the execution of the Purchase Agreement. No commitment fee was paid and no commitment shares were issued. The Company agreed to reimburse certain of Lucid’s legal fees up to approximately $0.1 million. The resale of the shares issuable pursuant to the Purchase Agreement is registered under the Company’s registration statement on Form S-1 (File No. 333-296678).

The facility commenced on June 15, 2026 upon effectiveness of the related resale registration statement. From commencement through September 30, 2026, the Company sold 654,734 shares of common stock under the facility for aggregate gross proceeds of approximately $27.2 million, including 280,516 shares sold during the three months ended September 30, 2026 for aggregate gross proceeds of approximately $11.0 million. Shares issued during the three months ended September 30, 2026 also include 60,222 shares sold on June 30, 2026 and issued on July 1, 2026. Shares issued under the facility are recorded at their fair value on the date of issuance. No shares were sold under the facility in September 2026. The Company evaluated the Purchase Agreement under ASC 815 and determined that the right to sell shares is a freestanding financial instrument that meets the definition of a derivative and does not qualify

15


for the scope exception for contracts indexed to, and classified in, the Company’s own equity, because the Exchange Cap may be removed by a vote of the Company’s stockholders. The facility is therefore accounted for as a derivative measured at fair value, with changes in fair value recognized in earnings. For the three and nine months ended September 30, 2026, the change in fair value of the derivative resulted in net losses of approximately $40,000 and $0.3 million, respectively, presented as change in fair value of ELOC derivative. No derivative asset or liability was recorded at September 30, 2026, because no draws were priced and unsettled at that date. The Company will remeasure the derivative at each reporting date and recognize the change in its fair value in earnings.

Common Stock

As of September 30, 2026, the Company had 200,000,000 shares of common stock authorized, 18,963,373 shares issued, and 18,728,211 shares outstanding.

Pre-Funded Warrants

As of September 30, 2026, the Company had 1,799,970 pre-funded warrants outstanding. These warrants were issued in connection with the automatic conversion of Series A convertible preferred stock immediately prior to the Company’s IPO, whereby one investor elected to receive pre-funded warrants in lieu of shares of common stock otherwise issuable upon conversion.

Each pre-funded warrant is exercisable for one share of common stock at a nominal exercise price of $0.01 per share, with the remaining exercise price having been paid at issuance. The warrants are exercisable at any time and remain outstanding until exercised in full, subject to customary beneficial ownership limitations, which generally prohibit exercise to the extent the holder would beneficially own more than 4.99% of the Company’s outstanding common stock.

The Company evaluated the pre-funded warrants in accordance with ASC 815-40 and concluded that they meet the criteria for equity classification. Accordingly, the pre-funded warrants are recorded within stockholders’ equity.

Common Stock Purchase Warrants

In connection with its Series A-1 preferred stock financings, the Company issued warrants to purchase 2,999,950 shares of common stock at an exercise price of $3.3334 per share, which became exercisable upon the effectiveness of the Company’s IPO registration statement and expire on March 22, 2027. During the three months ended September 30, 2026, holders exercised warrants for 2,969,950 shares on a net (cashless) basis, and the Company issued 2,121,947 shares of common stock upon these exercises through September 30, 2026. Each warrant is subject to a 4.99% beneficial ownership limitation, and 583,522 additional shares issuable upon one exercise were held in abeyance at September 30, 2026, to be issued as the limitation permits. As of September 30, 2026, warrants to purchase 29,999 shares of common stock remained outstanding.

 

The Company evaluated these warrants under ASC 815-40 and concluded that they meet the criteria for equity classification. Accordingly, these warrants are included within stockholders’ equity.

13.
Share-based Compensation

In 2023, the Company adopted the 2023 Stock Plan, followed by the adoption of the 2024 Stock Plan in 2024. In connection with the Company’s IPO, the Company adopted the 2026 Equity Incentive Plan (the “2026 Plan”), which superseded the 2023 Stock Plan and the 2024 Stock Plan with respect to future equity award grants. Under the Company’s equity compensation plans, employees, officers, directors, consultants, and advisors are eligible to receive stock options, restricted stock awards (“RSAs”), restricted stock units (“RSUs”), and other share-based awards. No further grants will be made under the 2023 Stock Plan or the 2024 Stock Plan following adoption of the 2026 Plan, although awards previously granted under those plans remain outstanding in accordance with their terms. The 2026 Plan initially authorized the issuance of 5,400,000 shares of common stock. In addition, up to 2,044,355 shares underlying awards previously granted under the 2024 Stock Plan may become available for issuance under the 2026 Plan to the extent such awards are forfeited, cancelled, expire unexercised or otherwise terminate without the issuance of shares. As of September 30, 2026, 3,456,230 shares remained available for future issuance under the 2026 Plan.

Share-Based Compensation Expense

The Company recorded total share-based compensation expense of $1.7 million and $3.2 million during the three and nine months ended September 30, 2026, respectively, and $17,873 and $46,361 during the three and nine months ended September 30, 2025, respectively, for the service periods through such dates using the straight-line attribution method, net of actual forfeitures, based on the

16


grant-date fair value of the share-based awards. The following table summarizes share-based compensation expense by function for the three and nine months ended September 30, 2026 and 2025:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Share-based compensation expense:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$

1,599,726

 

 

$

1,901

 

 

$

3,001,052

 

 

$

5,019

 

Research and development

 

 

117,315

 

 

 

15,972

 

 

 

175,968

 

 

 

41,342

 

Total share-based compensation expense

 

$

1,717,041

 

 

$

17,873

 

 

$

3,177,020

 

 

$

46,361

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

The Company has issued incentive stock options and non-statutory stock options that have a contractual life of 10 years and may be exercisable in cash or as otherwise determined by the board of directors. Vesting generally occurs over a period of four years.

The following table summarizes stock option activity under the Company’s equity compensation plans for the nine months ended September 30, 2026:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

Weighted

 

 

Remaining

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Shares

 

 

Exercise Price

 

 

Term (years)

 

Outstanding at December 31, 2025

 

9,072,974

 

 

$

0.91

 

 

 

—

 

Granted

 

1,227,911

 

 

 

7.03

 

 

 

—

 

Exercised

 

(4,880,578

)

 

 

0.10

 

 

 

—

 

Forfeited

 

(443,785

)

 

 

1.09

 

 

 

—

 

Outstanding at September 30, 2026

 

4,976,522

 

 

$

3.21

 

 

 

8.60

 

Vested and Exercisable at September 30, 2026

 

284,153

 

 

$

5.41

 

 

 

9.22

 

 

The weighted average grant date fair value of options granted during the three and nine months ended September 30, 2026, was $23.80 and $4.26, respectively. No options were granted during the three months ended September 30, 2025. The weighted average grant date fair value of options granted during the nine months ended September 30, 2025 was $0.81. As of September 30, 2026, total unrecognized compensation expense related to unvested stock option awards was approximately $4.6 million, which is expected to be recognized over a weighted-average remaining vesting period of approximately 3.5 years.

The fair value of each option granted during the three and nine months ended September 30, 2026 and the nine months ended September 30, 2025 was estimated on the date of grant using the Black-Scholes option-pricing model with the weighted average assumptions in the table below:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Expected volatility

 

102.7

%

 

 

—

 

 

 

56.4

%

 

 

49.3

%

Risk-free interest rate

 

4.7

%

 

 

—

 

 

 

4.0

%

 

 

4.1

%

Expected term (in years)

 

5.9

 

 

 

—

 

 

 

6.0

 

 

 

6.1

 

Expected dividend yield

 

0.0

%

 

 

—

 

 

 

0.0

%

 

 

0.0

%

Performance-based stock options

The stock option activity table above includes 709,890 option awards granted to the Company’s Non-Executive Chairman of the Board of Directors in December 2025, for which vesting is contingent upon the achievement of certain operational, financing, and market-based milestones, and 70,549 option awards granted to a member of executive management, for which vesting is contingent upon the achievement of operational performance milestones. The table also includes 45,000 option awards granted in September 2026 to another member of executive management, which vest monthly based on continued service and accelerate upon the achievement of specified performance milestones. Compensation expense associated with performance conditions is recognized only when management

17


determines it is probable that the applicable performance conditions will be achieved. As of September 30, 2026, the Company did not consider achievement of the operational milestone for the Chairman’s award or of the performance milestones for either member of executive management probable. Compensation expense for the market-based milestone is recognized over the derived service period whether or not the milestone is achieved, and any remaining unrecognized cost is recognized when the milestone is achieved. During the three months ended September 30, 2026, the market-based milestone was achieved, and the Company recognized the remaining compensation cost for that tranche. During the three and nine months ended September 30, 2026, the Company recognized $93,536 and $105,902, respectively, of share-based compensation expense associated with the Chairman’s performance-based options.

Restricted Stock

In May 2023, the Company issued 1,410,975 shares of restricted stock to a founder of the Company which were determined to have a de minimis value at the date of issuance. The shares vest over a 4-year period from the issuance date. The following table summarizes restricted stock activity for the nine months ended September 30, 2026:

 

 

Number of Shares

 

 

Weighted Average Grant
Date Fair Value

 

Unvested at December 31, 2025

 

499,720

 

 

$

0.00

 

Vested

 

(264,558

)

 

 

—

 

Unvested at September 30, 2026

 

235,162

 

 

$

0.00

 

 

Restricted Stock Units

In connection with the closing of the Company's IPO on March 18, 2026, the Company granted an aggregate of 2,683,680 RSUs under the 2026 Plan to its named executive officers, consisting of 1,341,840 RSUs to Serhii Kupriienko, then the Company's Secretary and Chief Executive Officer (Global), and 1,341,840 RSUs to Alexander Fink, the Company's President and Chief Executive Officer (U.S.). The grant date fair value of these awards was $5.00 per share, determined by reference to the IPO price, for an aggregate grant date fair value of $13.4 million.

The RSUs granted to Mr. Kupriienko were scheduled to vest in 48 substantially equal monthly installments commencing one month after the March 18, 2026 grant date, subject to his continued employment through each vesting date. Upon the termination of Mr. Kupriienko’s employment on August 19, 2026, his 1,202,065 unvested RSUs were forfeited, and the Company reversed the previously recognized compensation cost for those RSUs during the three months ended September 30, 2026. Mr. Kupriienko continues to serve as a member of the Board of Directors, and his stock options continue to vest in accordance with their terms during his service as a director. As originally granted, Mr. Fink's RSU award was subject to the same vesting schedule. On April 15, 2026, the Compensation Committee of the Board of Directors modified the vesting schedule of Mr. Fink's RSU award to align it with the expiration of his post-offering lock-up. As modified, 6/48ths of Mr. Fink's RSUs vested on September 16, 2026, with the remaining 42/48ths vesting in 42 substantially equal monthly installments thereafter, subject in each case to Mr. Fink's continued service through each vesting date. The total number of shares subject to the award, the grant date fair value, and the total service period were not changed by the modification. The Company evaluated the modification and concluded that no incremental compensation cost arose, because the fair value of the award immediately after the modification equaled its fair value immediately before the modification; accordingly, the Company continues to recognize the original grant date fair value over the requisite service period. Both awards provide for full acceleration of vesting upon a change of control, as defined in the 2026 Plan and the applicable award agreements. On September 16, 2026, the Company granted 95,000 RSUs under the 2026 Plan to Mykhailo Nestor, the Company’s Chief Product and Technology Officer, with a grant date fair value of $25.11 per share, the closing price of the Company’s common stock on the grant date. Of these RSUs, 70,000 vest in monthly installments beginning August 1, 2026 and 25,000 vest in monthly installments beginning August 1, 2027, subject in each case to continued service.

The Company recognizes share-based compensation expense related to these awards on a straight-line basis over the requisite service period of each award, with cumulative expense at each reporting date no less than the grant date fair value of the vested portion of each award. Forfeitures are accounted for as they occur. During the three and nine months ended September 30, 2026, the Company recognized $0.7 million and $1.7 million, respectively, of share-based compensation expense related to RSUs. As of September 30, 2026, total unrecognized share-based compensation expense related to unvested RSUs was $8.1 million, expected to be recognized over a weighted-average period of approximately 3.6 years. The following table summarizes RSU activity for the nine months ended September 30, 2026:

 

18


 

Number of Shares

 

 

Weighted Average Grant
Date Fair Value

 

Unvested at December 31, 2025

 

—

 

 

$

0.00

 

Granted

 

2,778,680

 

 

 

5.69

 

Vested

 

(308,963

)

 

 

5.09

 

Forfeited

 

(1,202,065

)

 

 

5.00

 

Unvested at September 30, 2026

 

1,267,652

 

 

$

6.48

 

 

14.
Net Loss Per Share

Net loss per common share is calculated in accordance with ASC 260, Earnings Per Share. Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, including 1,799,970 shares underlying pre-funded warrants, vested stock options exercisable for nominal consideration and 583,522 additional shares which are being held in abeyance in connection with warrants which were exercised during the three months and nine months ended September 30, 2026. Diluted net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding plus the dilutive effect of unvested restricted stock awards and outstanding warrants and options. The computation of diluted net loss per share does not include other potentially dilutive common stock equivalents in the weighted-average shares outstanding, as their effect would be anti-dilutive.

Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share for the three and nine months ended September 30, 2026 and 2025, are as follows:

 

 

Three and Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

Convertible preferred stock

 

 

—

 

 

 

4,292,985

 

Common stock warrants

 

 

29,999

 

 

 

1,199,980

 

Unvested restricted stock awards

 

 

235,162

 

 

 

587,906

 

Unvested restricted stock units

 

 

1,267,652

 

 

 

—

 

Unvested stock options exercisable for nominal consideration

 

 

1,410,975

 

 

 

3,198,210

 

Stock options

 

 

3,565,547

 

 

 

237,023

 

 

 

6,509,335

 

 

 

9,516,104

 

Amounts in the above table reflect the common stock equivalents.

 

15.
Segment Reporting

The Company operates as a single reportable segment, which is the provision of autonomous drone swarm software and artificial intelligence solutions, specializing in vendor-agnostic technologies that address critical operational challenges faced by modern military forces. The Company’s chief operating decision maker (“CODM”) is its President and Chief Executive Officer (U.S.), who became the Company’s principal executive officer following the realignment of the Company’s senior management on July 24, 2026, and who reviews financial information presented on a consolidated basis to assess performance and allocate resources. Prior to the realignment, the Company’s CODM was its Chief Executive Officer (Global). The CODM uses consolidated net loss, as reported on the Condensed Consolidated Statements of Operations and Comprehensive Loss, as the measure of segment profit or loss.

Other segment items included in consolidated net loss consist primarily of the change in the fair value of the ELOC derivative of $40,385 and $0.3 million for the three and nine months ended September 30, 2026, respectively, other income of $0.2 million and $0.5 million for the three and nine months ended September 30, 2026, respectively, and income tax expense of $1,622 for each of those periods. Other income consists primarily of foreign exchange gains and losses associated with the Company’s international operations, consulting services provided outside the normal course of operations, grant proceeds from a government entity, and interest earned on cash and cash equivalents held with financial institutions. For the three and nine months ended September 30, 2025, other segment items also included changes in the fair value of the SAFE liability of $2.6 million and $3.5 million, respectively. The measure of segment assets reviewed by the CODM is consolidated total assets, as reported on the Condensed Consolidated Balance Sheets.

The following table presents segment revenue, the significant segment expense categories regularly provided to the CODM and other segment items for the periods presented, reconciled to consolidated net loss, which is the measure of segment profit or loss:

 

19


 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenue

 

$

25,554

 

 

$

35,771

 

 

$

262,292

 

 

$

284,681

 

Cost of revenue

 

 

72,647

 

 

 

45,441

 

 

 

145,387

 

 

 

147,159

 

Selling, general and administrative

 

 

7,446,563

 

 

 

139,343

 

 

 

16,109,080

 

 

 

672,215

 

Research and development

 

 

1,979,116

 

 

 

641,686

 

 

 

5,270,730

 

 

 

1,741,140

 

Other segment items

 

 

(158,332

)

 

 

2,584,611

 

 

 

(164,592

)

 

 

3,420,636

 

Segment net loss

 

$

(9,314,440

)

 

$

(3,375,310

)

 

$

(21,098,313

)

 

$

(5,696,469

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

16.
Subsequent Events

The Company has evaluated subsequent events occurring after September 30, 2026 through the date these condensed consolidated financial statements were issued and, except as described below, identified no events requiring adjustment to or disclosure in these condensed consolidated financial statements.

On October 1, 2026, pursuant to the August 13, 2026 approval of the Board of Directors, the Company granted options to purchase an aggregate of 44,996 shares of common stock to its non-employee directors, with a grant-date fair value of approximately $80,000 per director and an exercise price of $16.38 per share, equal to the closing price of the common stock on the grant date. The options vest on the earlier of the first anniversary of the grant date or the date of the Company’s 2027 annual meeting of stockholders, subject to continued service.

On October 26, 2026, the Company entered into an agreement to acquire certain intellectual property of Vataga Drone, a Kyiv-based developer of first-person view (“FPV”) and interceptor drones, including airframe designs, initiation electronics, ground control equipment, development tooling and manufacturing documentation. The intellectual property is held by a newly formed Ukrainian company. On November 10, 2026, the Company completed the acquisition of 100% of that company for $0.5 million in cash and 393,701 shares of common stock, plus potential earnout consideration equal to 50% of that company’s cumulative revenue for 2027 and 2028 in excess of $5.0 million, payable 10% in cash and 90% in shares of common stock. Vataga Drone will continue to operate as an independent manufacturer. The sellers are required to transfer Vataga’s hardware research and development team to the acquired company within 60 days after the closing, subject to the acquired company obtaining critical enterprise status under Ukrainian law, and the Company may require the return of a proportionate share of the shares issued at closing if certain key members of the team do not transfer. The Company has also agreed to grant restricted stock units with an aggregate value of $1.0 million to certain members of the team and other individuals within ten business days after the closing, subject to approval by the Company’s Board of Directors or its Compensation Committee, vesting over 12 to 24 months subject to continued service.

On November 2, 2026, the Company’s stockholders approved the issuance of shares of common stock in connection with the pending acquisition of Ratel described in Note 10. The acquisition is expected to close in November 2026, subject to the satisfaction of the remaining closing conditions, and had not closed as of the date these condensed consolidated financial statements were issued.

On November 16, 2026, the Company issued the Promissory Note, which provides the Company with a delayed-draw facility of up to $10.0 million. The Promissory Note matures on January 16, 2028, subject to acceleration. The Investor has agreed to retain cash and cash equivalents in an amount at least equal to the undrawn amount of the facility. Advances bear interest at 7.00% per year, payable quarterly in kind or, with the consent of the Investor and subject to conditions, in shares of common stock, and the interest rate increases by 5.00% per year while an event of default continues. The Company may also pay any prepayment premium in shares of common stock, subject to conditions. Shares issued under the Promissory Note are valued at $8.73 per share (the closing price per share of common stock on the Nasdaq Capital Market on the trading day prior to the entry into the Promissory Note) and are subject to a beneficial ownership limitation of 4.99% of the common stock outstanding on the date of issuance and, absent stockholder approval, to a cap of 19.99% of the shares outstanding on November 16, 2026. The Company paid an origination fee of $100,000 and agreed to reimburse up to $35,000 of the Investor’s legal expenses. The Company may prepay the Promissory Note in whole, but not in part. A prepayment premium of $250,000 applies during the first three months after issuance and $500,000 during months three through six, in each case reduced by any interest previously paid in shares, and no premium applies after six months. The Promissory Note contains customary covenants, including limits on additional indebtedness and liens and a requirement to use advances for general corporate and working capital purposes, and customary events of default. As of the date the condensed consolidated financial statements were issued, no amounts had been borrowed and no shares had been issued under the Promissory Note.

 

 

 

 

20


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and the related notes and the discussion under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for the fiscal year ended December 31, 2025 included in the final prospectus for our initial public offering (“IPO”), dated as of March 16, 2026 and filed with the Securities and Exchange Commission (the “SEC”), pursuant to Rule 424(b)(4) on March 17, 2026. This discussion, particularly information with respect to our future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, includes forward-looking statements that involve risks and uncertainties as described under the heading "Special Note Regarding Forward-Looking Statements" in this Quarterly Report on Form 10-Q. You should review the disclosure under the heading "Risk Factors" in this Quarterly Report on Form 10-Q for a discussion of important factors that could cause our actual results to differ materially from those anticipated in these forward-looking statements.

Overview

We are a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies that address critical operational challenges faced by modern military forces. Our primary customer base consists of drone manufacturers who license our software for integration with their hardware platforms. While not our direct customers, the ultimate end-users of our Swarmer-enabled systems are military forces and defense organizations.

With a focus on affordability, rapid development, and proven combat performance, we deliver software platforms and AI systems that enable military organizations to deploy and coordinate large-scale unmanned systems operations without requiring proportional increases in trained operators. Our primary mission areas include autonomous swarm coordination, multi-domain unmanned systems integration, AI-powered collaborative autonomy, and command and control software for distributed robotic operations.

Our combat-tested approach, proven deployment record since 2024, and demonstrated execution of over 100,000 combat missions flown by drones that were equipped with the Swarmer Operating System ("Swarmer OS"), operating at varying degrees of autonomy depending on each end-user’s requirements and tactics, have enabled us to deliver operational value to drone manufacturers, defense system integrators, and the military end-users they serve.

Our net loss was $9.3 million and $3.4 million for the three months ended September 30, 2026 and 2025, respectively, and $21.1 million and $5.7 million for the nine months ended September 30, 2026 and 2025, respectively. Historically, substantially all of our net losses have resulted from costs incurred in connection with our research and development related to engineering of our core software technology products, and more recently, from selling, general and administrative costs associated with our operations due to a rise in stock-based compensation, consulting and professional services as we prepared to operate as a public company, increased travel, office supplies, and rent as we ramped up our operations and opened new corporate offices in the U.S. and EU.

Recent Developments

Sale of Series A-1 Preferred Stock

During January 2026, the Company sold 558,116 shares of Series A-1 convertible preferred stock at a price of $6.2711 per share for gross proceeds of approximately $3.5 million.

Forward Stock Split

On February 18, 2026, our board of directors approved an amendment to our amended and restated certificate of incorporation providing a 1.8813-for-1 forward stock split of our issued and outstanding common stock. The forward stock split became effective on February 18, 2026.

Initial Public Offering

On March 18, 2026, we completed our IPO, in which we issued and sold 3,450,000 shares of our common stock, which includes the full exercise by the underwriters of their option to purchase 450,000 additional shares of our common stock, at a public offering price of $5.00 per share, which resulted in gross proceeds of $17.3 million, before deducting underwriting discounts and commissions and offering expenses. Our common stock began trading on the Nasdaq Capital Market on March 17, 2026.

21


Equity Line of Credit

On June 10, 2026, we entered into a common stock purchase agreement (“Purchase Agreement”) in connection with an equity line of credit (“ELOC”) with Lucid Capital Markets, LLC (“Lucid”), providing us with the ability, at our discretion, to sell up to 3,000,000 shares of our common stock over a 24-month period, subject to the terms and limitations of the agreement. We control the timing and amount of any sales and are under no obligation to sell any shares. Shares sold are priced at 98% of the volume-weighted average price of the common stock determined as provided in the Purchase Agreement (a 2% discount). Sales are subject to a 4.99% beneficial ownership limitation and, absent stockholder approval, to an aggregate limit of 2,240,930 shares (the “Exchange Cap”), representing approximately 19.99% of the shares of common stock outstanding at the time of the execution of the Purchase Agreement. No commitment fee was paid and no commitment shares were issued. We agreed to reimburse certain of Lucid’s legal fees up to approximately $0.1 million. The resale of the shares issuable pursuant to the Purchase Agreement is registered under the Company’s registration statement on Form S-1 (File No. 333-296678).

The facility became available on June 15, 2026 following the effectiveness of the related resale registration statement. From commencement through September 30, 2026, we sold 654,734 shares of common stock under the ELOC for aggregate gross proceeds of approximately $27.2 million, including 280,516 shares sold during the three months ended September 30, 2026 for aggregate gross proceeds of approximately $11.0 million. No shares were sold under the ELOC in September 2026. Because the average price of our sales under the ELOC has been below the Base Price defined in the Purchase Agreement, the Exchange Cap applies, and absent stockholder approval we may sell up to an additional 1,586,196 shares under the ELOC.

SkyKnight Master Supplier Agreements

On May 11, 2026, our wholly owned subsidiary, Swarmer Estonia OÜ ("Estonia"), a private limited company organized under the laws of Estonia, entered into a Master Supplier Agreement (the “MB MSA”) with Meta Bureau LLC (“MB”) for the use of our proprietary software in MB’s quadcopter bombers and other unmanned aerial vehicles pursuant to three licenses. The MB MSA includes initial lump-sum license fees in an aggregate amount of approximately $2.9 million, ongoing support services, and has an initial term of one year, which term shall automatically renew for successive one year periods subject to termination upon 30 days’ written notice. The MB MSA also provides for additional software upgrades upon MB’s election with additional fees of up to approximately $10.4 million upon any such election in full.

On June 25, 2026, Estonia entered into an Amended and Restated Master Supplier Agreement (the “A&R MB MSA”) with MB, pursuant to which the initial lump-sum license fees payable by MB were reduced to approximately $2.5 million and the option for additional software upgrades under the MB MSA was eliminated. The A&R MB MSA retains the initial one-year term, which shall automatically renew for successive one-year periods subject to termination upon 30 days’ written notice.

On June 25, 2026, in connection with the entry into the A&R MB MSA, Estonia entered into a Master Supplier Agreement (the “Progress MSA”) with Progress TRW S.R.O. (“Progress”) for the use of our proprietary software in MB’s quadcopter bombers and other unmanned aerial vehicles. The Progress MSA includes initial lump-sum license fees in an aggregate amount of approximately $1.4 million, for an aggregate of approximately $3.9 million in initial lump-sum license fees payable to us pursuant to the A&R MB MSA and Progress MSA. Additionally, the Progress MSA provides for additional software upgrades upon Progress’ election, with additional fees of up to approximately $10.4 million upon any such election in full, which upgrades were previously reflected in the MB MSA prior to its amendment. The Progress MSA has an initial term of one year, which term shall automatically renew for successive one-year periods subject to termination upon 30 days’ written notice. See Note 9 to our unaudited condensed consolidated financial statements for further discussion.

Management Realignment

On July 24, 2026, our Board of Directors approved a realignment of our senior management team and a reallocation of the duties and responsibilities among certain of our executives, each effective immediately. In connection with the realignment, Alexander Fink, our President and Chief Executive Officer (U.S.), assumed additional responsibilities and became our principal executive officer, reporting directly to the Board. Mr. Fink’s compensation was unchanged in connection with the realignment. On July 26, 2026, Serhii Kupriienko resigned as our Chief Executive Officer (Global) and as Chief Executive Officer (Global) of ARS, effective immediately, and Mr. Kupriienko’s employment with us terminated on August 19, 2026. Mr. Kupriienko continues to serve as a member of our Board of Directors.

22


 

Warrant Exercises

During the three months ended September 30, 2026, holders of warrants issued in connection with our Series A-1 preferred stock financings exercised warrants for 2,969,950 shares of common stock on a net (cashless) basis. We issued 2,121,947 shares of common stock upon these exercises through September 30, 2026, and 583,522 additional shares are being held in abeyance under the 4.99% beneficial ownership limitation in the applicable warrant. We received no cash proceeds from these exercises.

Pending Acquisition of Ratel Robotics

On September 9, 2026, we entered into an agreement to acquire 100% of the equity interests in LLC “JK Land Vehicles,” a Ukrainian manufacturer of unmanned ground vehicles doing business as Ratel Robotics (“Ratel”) (the “Acquisition”), for $7.2 million in cash, subject to adjustment, and 1,064,942 shares of our common stock at closing, plus up to $7.2 million in cash upon the achievement of revenue and operating income targets for fiscal year 2026 and up to 4,422,125 additional shares of common stock upon the achievement of such targets for fiscal years 2026 through 2028. Our stockholders approved the share issuance pursuant to Nasdaq Listing Rule 5635(a) at a special meeting held on November 2, 2026. Completion of the Acquisition remains subject to customary closing conditions, and as of the date of this Quarterly Report, the Acquisition had not closed. Unless specifically stated, this Quarterly Report does not give effect to the Acquisition. See Note 10 to our unaudited condensed consolidated financial statements for further discussion.

Memorandum of Understanding with Vectus Air Defense Systems

On September 23, 2026, we entered into a nonbinding memorandum of understanding with Vectus Air Defense Systems LLC (“Vectus”) to manufacture, sell and deploy end-to-end mobile air defense systems in eligible markets, subject to export control, sanctions, procurement and other government requirements. Under the memorandum of understanding, Vectus has indicated its intent to purchase and deploy at least 40 of our systems in the first year and 80 or more in the second year. Final quantities, pricing, financing, specifications and delivery schedules remain subject to the negotiation and execution of definitive agreements, and there can be no assurance that definitive agreements will be entered into or that Vectus will purchase any systems. In connection with this program, we plan to establish a manufacturing facility in Poland. Erik Prince, the Non-Executive Chairman of our Board of Directors, is the Manager of Vectus, and we hold a 20% interest in Vectus, which we account for under the equity method. Any definitive agreements with Vectus will be subject to review and approval under our conflict of interest policy.

Acquisition of Vataga Drone Intellectual Property

On October 26, 2026, we entered into an agreement to acquire certain intellectual property of Vataga Drone, a Kyiv-based developer of first-person view (“FPV”) and interceptor drones, including airframe designs, initiation electronics, ground control equipment, development tooling and manufacturing documentation. The intellectual property is held by a newly formed Ukrainian company. On November 10, 2026, we completed the acquisition of 100% of that company for $0.5 million in cash and 393,701 shares of our common stock, plus potential earnout consideration equal to 50% of that company’s cumulative revenue for 2027 and 2028 in excess of $5.0 million, payable 10% in cash and 90% in shares of our common stock. Vataga Drone will continue to operate as an independent manufacturer. The sellers are required to transfer Vataga’s hardware research and development team to the acquired company within 60 days after the closing, subject to the acquired company obtaining critical enterprise status under Ukrainian law, and we may require the return of a proportionate share of the shares issued at closing if certain key members of the team do not transfer. We have also agreed to grant restricted stock units with an aggregate value of $1.0 million to certain members of the team and other individuals within ten business days after the closing, subject to approval by our Board of Directors or its Compensation Committee, vesting over 12 to 24 months subject to continued service. See Note 16 to our unaudited condensed consolidated financial statements.

 

23


Factors Affecting Our Performance

Acquiring New Customers

We believe there is substantial opportunity to continue to grow our customer base. We intend to drive new customer acquisitions by continuing to invest significantly in sales and marketing to engage our prospective customers, increase brand awareness and drive adoption of our software platforms and AI systems. We also plan to continue to invest in building brand awareness within the defense communities. As of September 30, 2026 and 2025, we had approximately six and seven customers, respectively. Our ability to attract new customers will depend on a number of factors, including the effectiveness and pricing of our software platforms, AI systems, offerings of our competitors, and the effectiveness of our marketing efforts.

Expanding our product portfolio and team through strategic acquisitions

We believe there is a significant opportunity to acquire best-in-class technologies and world-class teams in related and adjacent defense technology markets. As a hardware-agnostic software company, we have good visibility into the ecosystem and real-world data that helps us understand which technologies work well and which teams deliver good value to the battlefield. We plan to explore the market and look for opportunities to expand our presence and market position through strategic acquisitions, and we believe that they will contribute to our long-term growth.

Sustaining Innovation and Technology Leadership

Our success is dependent on our ability to sustain innovation and technology leadership in order to maintain our competitive advantage. We believe that we are building software platforms and AI systems that will enable military organizations to deploy and coordinate large-scale unmanned systems operations without requiring proportional increases in trained operators. We employ a business-to-business-to-government (“B2B2G”) model that enables manufacturers to enhance products with advanced autonomous capabilities without developing proprietary swarm technology, significantly reducing research and development (“R&D”) costs and time-to-market. Our efficient B2B2G model enables us to prioritize significant investment in innovation. We intend to continue to invest in building additional products, features and functionality that expand our capabilities and facilitate the extension of our software platforms and AI systems to new use cases. We also intend to continue to evaluate strategic acquisitions and investments in businesses and technologies to drive product and market expansion. Our future success is dependent on our ability to successfully develop, market and sell existing and new products to customers.

Expanding Internationally

We believe there is a significant opportunity to expand usage of our software platforms and AI systems. For the nine months ended September 30, 2026, substantially all of our revenue was derived from the SkyKnight counterparty group and one other customer, all located in Europe. We have made and plan to continue to make significant investments to expand geographically, particularly in the European Union (“EU”) and United States (“U.S.”). Although these investments may adversely affect our operating results in the near term, we believe that they will contribute to our long-term growth.

Components of Results of Operations

Revenue

We earn revenue through software license sales. License sales include multiple performance obligations, including the license, video streaming and cloud storage services and updates and technical support. The license is a non-exclusive, non-transferable, non-sublicensable license to use our software. Support and maintenance include access to our support center, software upgrades and updates, and error investigation. We recognize revenues from software licenses at a point in time and generally when the software is activated within the corresponding hardware it was installed. Revenues from maintenance and support, including data storage-related services, are recognized ratably over the contractual term which is generally one year.

24


Cost of Revenue

Our cost of revenue consists primarily of third-party hosting fees and certain allocated consulting and professional service costs related to engineering and sales support.

Operating Expenses

R&D Expenses

Our R&D expense consists primarily of consulting and outside professional services costs related to engineering and product development, stock-based compensation, and other supporting overhead expenses associated with the development of our software offerings.

Development costs of computer software to be sold, leased, or otherwise marketed are subject to capitalization beginning when a product’s technological feasibility has been established and ending when a product is available for general release to customers. In most instances, the Company’s products are released soon after technological feasibility has been established. Costs incurred subsequent to achievement of technological feasibility were not significant, and software development costs were expensed as incurred.

Selling, General and Administrative Expenses

Selling, general and administrative expenses consist primarily of consulting fees for our management team, facilities related costs, legal fees related to intellectual property, corporate matters and acquisitions, other professional fees for accounting and consulting services, insurance, and other administrative expenses.

We expect that our selling, general and administrative expense will increase for the foreseeable future as we continue to support our expanding headcount and operation to support the growth of our business.

Other Income (Expense)

Change in Fair Value of SAFE Liability

Change in fair value of SAFE liability consists of gains and losses associated with the change in fair value of our SAFE liabilities and primarily attributable to the timing and probability in which we anticipated completing a qualified financing to which the SAFE liabilities would be settled and no longer subject to remeasurement each reporting period.

Change in the Fair Value of ELOC Derivative

Change in fair value of ELOC derivative consists of gains and losses associated with the change in fair value of the ELOC derivative each reporting period.

Other Income

Other income is primarily related to interest earned on our cash and cash equivalents held with financial institutions, foreign exchange gains and losses associated with our international operations, consulting services provided outside the normal course of business and government grant proceeds.

25


Consolidated Results of Operations

Comparison of the three and nine months ended September 30, 2026 and 2025

The following table sets forth key components of the unaudited condensed consolidated statements of operations data during the three and nine months ended September 30, 2026 and 2025:

 

 

 

Three Months Ended September 30,

 

 

 

 

 

Nine Months Ended September 30,

 

 

 

 

 

 

2026

 

 

2025

 

 

$ Change

 

 

2026

 

 

2025

 

 

$ Change

 

Revenue

 

$

25,554

 

 

$

35,771

 

 

$

(10,217

)

 

$

262,292

 

 

$

284,681

 

 

$

(22,389

)

Cost of revenue

 

 

72,647

 

 

 

45,441

 

 

 

27,206

 

 

 

145,387

 

 

 

147,159

 

 

 

(1,772

)

Gross margin

 

 

(47,093

)

 

 

(9,670

)

 

 

(37,423

)

 

 

116,905

 

 

 

137,522

 

 

 

(20,617

)

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

7,446,563

 

 

 

139,343

 

 

 

7,307,220

 

 

 

16,109,080

 

 

 

672,215

 

 

 

15,436,865

 

Research and development

 

 

1,979,116

 

 

 

641,686

 

 

 

1,337,430

 

 

 

5,270,730

 

 

 

1,741,140

 

 

 

3,529,590

 

Total operating expenses

 

 

9,425,679

 

 

 

781,029

 

 

 

8,644,650

 

 

 

21,379,810

 

 

 

2,413,355

 

 

 

18,966,455

 

Loss from operations

 

 

(9,472,772

)

 

 

(790,699

)

 

 

(8,682,073

)

 

 

(21,262,905

)

 

 

(2,275,833

)

 

 

(18,987,072

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of SAFE liability

 

 

—

 

 

 

(2,624,431

)

 

 

2,624,431

 

 

 

—

 

 

 

(3,493,431

)

 

 

3,493,431

 

Change in fair value of ELOC derivative

 

 

(40,385

)

 

 

—

 

 

 

(40,385

)

 

 

(291,840

)

 

 

—

 

 

 

(291,840

)

Other income

 

 

200,339

 

 

 

39,820

 

 

 

160,519

 

 

 

458,054

 

 

 

72,795

 

 

 

385,259

 

Loss before income taxes

 

 

(9,312,818

)

 

 

(3,375,310

)

 

 

(5,937,508

)

 

 

(21,096,691

)

 

 

(5,696,469

)

 

 

(15,400,222

)

Income tax expense

 

 

(1,622

)

 

 

—

 

 

 

(1,622

)

 

 

(1,622

)

 

 

—

 

 

 

(1,622

)

Net loss

 

$

(9,314,440

)

 

$

(3,375,310

)

 

$

(5,939,130

)

 

$

(21,098,313

)

 

$

(5,696,469

)

 

$

(15,401,844

)

 

Revenue

Revenue was less than $0.1 million and $0.3 million for the three and nine months ended September 30, 2026, respectively, as compared to less than $0.1 million and $0.3 million for the three and nine months ended September 30, 2025, respectively. Revenue for the three months ended September 30, 2026 consisted of support revenue under the Progress MSA, which is recognized ratably over the 12-month support period; no license revenue was recognized in the period. Of the $1.5 million invoiced under the SkyKnight master supplier agreements, $0.2 million was recognized as revenue and $0.1 million was recorded as deferred revenue, with the remainder presented as advances received under combined arrangement, reflecting the reduction of the transaction price for consideration payable to the counterparty group. See Note 9 to our unaudited condensed consolidated financial statements for further discussion.

Cost of Revenue

Cost of revenue increased by less than $0.1 million for the three months ended September 30, 2026 and was relatively consistent for the nine months ended September 30, 2026, as compared to the prior year periods. Cost of revenue consists of cloud storage and hosting costs to maintain our software infrastructure, which do not vary with the timing and volume of license deliveries. The increase for the three months ended September 30, 2026 reflects higher cloud storage and hosting usage.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased from $0.1 million and $0.7 million during the three and nine months ended September 30, 2025, respectively, to $7.4 million and $16.1 million during the three and nine months ended September 30, 2026, respectively.

The $7.3 million increase for the three months ended September 30, 2026, as compared to the prior year period, reflects selling, general and administrative expenses of $7.4 million in the current period, compared to $0.1 million in the prior year period. Selling, general and administrative expenses for the three months ended September 30, 2026 consisted primarily of $3.2 million of professional fees, including $2.1 million of legal fees, largely in connection with our pending acquisition of Ratel and the related SEC filings, $0.6 million of accounting fees and $0.5 million of other professional and consulting fees; $1.6 million of salaries, wages, bonuses, payroll taxes and benefits; $1.6 million of stock-based compensation; $0.4 million of travel, office supplies and rent; $0.3 million of software subscriptions and license fees; $0.2 million of public relations, marketing and conferences; and $0.1 million of insurance.

The $15.4 million increase for the nine months ended September 30, 2026, as compared to the prior year period, was primarily attributable to a $5.2 million increase in professional fees, consisting of a $2.3 million increase in legal fees, largely in connection with our pending acquisition of Ratel and the related SEC filings, a $1.0 million increase in accounting fees, $0.9 million of fees related to

26


our IPO, a $0.6 million increase in other professional and consulting fees and $0.4 million of recruiting and cybersecurity consulting fees; a $4.1 million increase in salaries, wages, bonuses, payroll taxes and benefits associated with increased headcount; and a $3.0 million increase in stock-based compensation. In addition, our operation as a public company resulted in incremental expenses of $0.6 million for software subscriptions and license fees, $0.5 million for public relations, marketing and conferences, $0.3 million for insurance, $0.1 million for board-related costs and $0.1 million for depreciation. We also increased travel, office supplies and rent by approximately $1.3 million as we ramped up our operations and opened new corporate offices in the U.S. and EU.

R&D Expenses

R&D expenses increased from $0.6 million and $1.7 million for the three and nine months ended September 30, 2025, respectively, to $2.0 million and $5.3 million for the three and nine months ended September 30, 2026, respectively. The $1.3 million increase for the three months ended September 30, 2026, as compared to the prior year period, reflects R&D expenses of $2.0 million in the current period, compared to $0.6 million in the prior year period. R&D expenses for the three months ended September 30, 2026 consisted primarily of $1.3 million of salary, wages and benefits associated with increased headcount, $0.5 million of R&D hardware, testing and software related to engineering and product development initiatives, and $0.1 million of stock-based compensation. The $3.5 million increase for the nine months ended September 30, 2026, as compared to the prior year period, was driven primarily by a $2.1 million increase in salary, wages and benefits associated with increased headcount, a $1.3 million increase in R&D hardware, testing and software costs related to engineering and product development initiatives, and a $0.1 million increase in stock-based compensation, partially offset by a $0.1 million decrease in outsourced engineering consulting fees.

Change in Fair Value of SAFE Liability

During the three and nine months ended September 30, 2025, we recorded noncash charges of $2.6 million and $3.5 million, respectively, associated with the change in fair value of our SAFE liabilities and primarily attributable to the timing and probability in which we anticipated completing a qualified financing to which the SAFE liabilities would be settled and no longer subject to remeasurement each reporting period.

Change in Fair Value of ELOC Derivative

During the three and nine months ended September 30, 2026, we recorded noncash charges of approximately $40,000 and $0.3 million, respectively, for the change in fair value of the ELOC derivative.

Other Income

Other income was $0.2 million and $0.5 million for the three and nine months ended September 30, 2026, respectively. Other income for the nine months ended September 30, 2026 consisted primarily of $0.4 million of interest earned on our cash and cash equivalents and a $0.1 million net foreign exchange gain associated with our international operations, partially offset by $0.1 million of interest expense.

Liquidity and Capital Resources

Source of Liquidity

Since our inception in 2023, we have devoted substantially all of our efforts and financial resources to building our organization, including raising capital, research and development, business planning, and providing selling, general and administrative support for these operations. To date, we have funded our operations primarily through the issuance of SAFEs, the sale of Series A-1 preferred stock, the issuance of common stock in our IPO and the sale of our common stock through our ELOC with Lucid.

From inception through September 30, 2026, we raised aggregate net proceeds of approximately $3.2 million from the issuance and sale of SAFEs. The SAFE instruments were previously accounted for as liabilities and remeasured at fair value each reporting period until their conversion into Series A preferred stock in connection with the Company’s preferred stock financing completed during 2025. In multiple closings held from September 2025 through January 2026, we issued and sold an aggregate of 2,491,721 shares of Series A-1 convertible preferred stock for aggregate gross proceeds of approximately $15.6 million. In connection with these financings, we issued warrants to purchase 2,999,950 shares of common stock at an exercise price of $3.3334 per share, which became exercisable upon the effectiveness of our IPO registration statement and expire on March 22, 2027. During the three months ended September 30, 2026, holders exercised warrants for 2,969,950 shares on a net (cashless) basis, and we received no cash proceeds from these exercises. As of September 30, 2026, warrants to purchase 29,999 shares remained outstanding.

27


On March 18, 2026, we completed our IPO, in which we issued and sold 3,450,000 shares of common stock, including the full exercise by the underwriters of their option to purchase an additional 450,000 shares of common stock, at a public offering price of $5.00 per share, resulting in gross proceeds of approximately $17.3 million before deducting underwriting discounts, commissions and offering expenses.

On June 10, 2026, we entered into an ELOC with Lucid providing us with the ability, at our discretion, to sell up to 3,000,000 shares of our common stock over a 24-month period, subject to the terms and limitations of the agreement. The facility became available on June 15, 2026 following the effectiveness of the related resale registration statement. From commencement through September 30, 2026, we sold 654,734 shares of common stock under the ELOC for aggregate gross proceeds of approximately $27.2 million, including 280,516 shares sold during the three months ended September 30, 2026 for aggregate gross proceeds of approximately $11.0 million. Absent stockholder approval, the Exchange Cap limits additional sales under the ELOC to 1,586,196 shares.

Future Funding Requirements

Our primary uses of cash are to fund our operations, which consist primarily of selling, general and administrative expenses, including consulting and professional fees and the costs associated with being a public company, and research and development expenditures related to our products. We anticipate that we will continue to incur significant and increasing expenses for the foreseeable future as we expand our corporate infrastructure, further our research and development initiatives, and incur costs associated with sales and marketing. We may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. We anticipate that we may require additional funding in connection with our continuing operations.

Based on our current operating plan, we believe that our existing cash and cash equivalents, together with proceeds from sales of our common stock under the ELOC and cash expected to be generated by Ratel’s operations following the closing of the acquisition and available to us through distributions from Ratel, will be sufficient to fund our operations and the cash consideration payable for the Ratel acquisition, including the contingent cash consideration that may become payable in 2027, for at least the next twelve months from the date the financial statements included in this Quarterly Report on Form 10-Q are issued. However, ELOC proceeds depend on the market price and trading volume of our common stock, which are outside our control. Ratel’s cash flows depend in part on Ratel obtaining new orders, including customer prepayments, that are not yet under contract, and on Ratel’s continued operations in Ukraine during the ongoing war, and cash held by Ratel is located in Ukraine and is subject to the currency controls of the National Bank of Ukraine and to tax on distributions, which may limit or delay its transfer to us. Without these sources, our existing cash and cash equivalents would not be sufficient, which raised substantial doubt about our ability to continue as a going concern. On November 16, 2026, we issued a promissory note (the “Promissory Note”) to an institutional investor (the “Investor”) as an additional measure to alleviate this substantial doubt. The Promissory Note provides us with a committed facility to borrow up to $10.0 million through January 16, 2028, at an interest rate of 7.00% per year, and the Investor has agreed to retain cash and cash equivalents in an amount at least equal to the undrawn amount of the facility. We believe that our existing cash and cash equivalents, together with the borrowings available under the Promissory Note, will be sufficient for at least the next twelve months without relying on ELOC proceeds or distributions from Ratel, and that the Promissory Note alleviates the substantial doubt. If ELOC proceeds or Ratel’s cash flows are lower than we expect, or if we are unable to transfer cash from Ratel when needed, we will need to raise additional capital through other equity or debt financings, which may not be available on acceptable terms, or at all. See Notes 2, 10 and 16 to our unaudited condensed consolidated financial statements.

 

Cash Flows

The following table sets forth our cash flow activity for the nine months ended September 30, 2026 and 2025:

 

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

Cash used in operating activities

 

$

(17,469,016

)

 

$

(2,050,616

)

Cash used in investing activities

 

 

(576,375

)

 

 

(40,011

)

Cash provided by financing activities

 

 

46,132,352

 

 

 

3,380,000

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(89,170

)

 

 

14,609

 

Net increase (decrease) in cash and cash equivalents

 

$

27,997,791

 

 

$

1,303,982

 

 

28


Operating Activities

Net cash used in operating activities was $17.5 million for the nine months ended September 30, 2026, and reflected our net loss of $21.1 million, partially offset by non-cash share-based compensation of $3.2 million, the change in advances received under the combined arrangement described in Note 9 and changes in net working capital.

During the nine months ended September 30, 2025, cash used in operating activities was $2.1 million, and reflected our net loss of $5.7 million, which included the $3.5 million non-cash change in fair value of the SAFE liability.

Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2026, was approximately $0.6 million and related to the $0.5 million purchase of property and equipment and the $0.1 million purchase of intangibles. Net cash used in investing activities for the nine months ended September 30, 2025 was less than $0.1 million and related to the purchase of property and equipment.

Financing Activities

During the nine months ended September 30, 2026, cash provided by financing activities was $46.1 million and primarily related to proceeds from the IPO, proceeds from the issuance of common stock under our ELOC with Lucid, the sale of Series A-1 convertible preferred stock and the exercise of stock options. During the nine months ended September 30, 2025, cash provided by financing activities was $3.4 million and primarily related to the sale of Series A convertible preferred stock and common stock warrants.

Contractual Obligations

Our contractual obligations consist primarily of operating lease commitments, a D&O insurance premium financing arrangement, our commitment to procure, deploy, and integrate our proprietary software onto unmanned aerial vehicles for use by designated military units of the Armed Forces of Ukraine, and, upon the closing of the Ratel acquisition, the cash consideration payable under the purchase agreement, including the contingent cash consideration that may become payable in 2027. See Note 8, “Accrued Expenses and Other Current Liabilities,” Note 9, “Advances Received Under Combined Arrangement,” and Note 10, “Commitments and Contingencies,” to our unaudited condensed consolidated financial statements for further details.

Critical Accounting Estimates

Management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported expenses during the reporting periods. These estimates are based on historical experience and other factors that management believes are reasonable under the circumstances. Actual results may differ from these estimates, and such differences may be material.

There have been no material changes to the methodologies applied by management in determining critical accounting estimates during the three and nine months ended September 30, 2026 and 2025, as compared to those described in our audited financial statements included in our final prospectus for our IPO, except as described below. For additional information regarding our critical accounting policies and estimates, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates” in our final prospectus for our IPO, dated as of March 16, 2026 and filed with the SEC, pursuant to Rule 424(b)(4) on March 17, 2026.

Combined Arrangement. During the second quarter of 2026, we entered into the combined arrangement with the SkyKnight counterparty group described in Note 9 to our unaudited condensed consolidated financial statements. Accounting for this arrangement requires significant judgment. This includes the determination that the agreements form a single arrangement and the estimate of the standalone selling prices used to allocate the transaction price among the performance obligations. It also includes the estimate of the fair value of the unmanned aerial vehicles to be procured, which determines the amount of our payments that is accounted for as consideration payable to a customer. We estimated the fair value of the vehicles at $1.8 million, and the $0.4 million paid in excess of that amount was accounted for as consideration payable to a customer. Changes in these estimates could change the amount and timing of revenue recognized under the arrangement.

ELOC Derivative. The ELOC derivative is measured at fair value on a recurring basis and is classified within Level 3 of the fair value hierarchy. Its fair value reflects significant unobservable inputs, including the expected timing and volume of future sales under

29


the facility. Changes in these inputs could result in material changes in the fair value of the derivative and in our results of operations. See Notes 6 and 12 to our unaudited condensed consolidated financial statements.

Recent Accounting Pronouncements

See Note 3 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for a description of recent accounting pronouncements applicable to our financial statements.

Emerging Growth Company and Smaller Reporting Company Status

We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (“JOBS Act”), and we may remain an emerging growth company for up to five years following the completion of our IPO. For so long as we remain an emerging growth company, we are permitted and intend to rely on certain exemptions from various public company reporting requirements, including not being required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section 404(b) of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. Accordingly, the information contained herein may be different than the information you receive from other public companies in which you hold stock.

In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period, and therefore, we are not subject to the same requirements to adopt new or revised accounting standards as other public companies that are not emerging growth companies; however, we may adopt certain new or revised accounting standards early. We will remain an “emerging growth company” until the earliest to occur of: (i) the last day of the fiscal year in which we have $1.235 billion or more in annual revenue; (ii) the date on which we first qualify as a large accelerated filer under the rules of the SEC; (iii) the date on which we have, in any prior three-year period, issued more than $1.0 billion in non-convertible debt securities; and (iv) the last day of the fiscal year following the fifth anniversary of the consummation of our IPO.

We are also a smaller reporting company as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter.

Off Balance Sheet Arrangements

We did not have, during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

As a smaller reporting company, we are not required to provide the information required by this Item.

Item 4. Controls and Procedures.

Internal Control Over Financial Reporting

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. GAAP. Under standards established by the Public Company Accounting Oversight Board, or PCAOB, a deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or personnel, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. The PCAOB defines a material weakness as a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented, or detected and corrected, on a timely basis.

We have identified the following material weaknesses in the design of our internal controls:

30


•
We have not designed and implemented controls to ensure we can record, process, summarize, and report financial data.
•
We have not yet designed and implemented user access controls to ensure appropriate segregation of duties that would adequately restrict user and privileged access to the financially relevant systems and data to appropriate personnel.
•
We did not design and maintain effective controls associated with the timing of when we recognized revenue, and controls related to the timing of when we accrue and recognize expenses.
•
We also do not have a properly designed internal control system that identifies critical processes and key controls.

We are in the process of remediating such material weaknesses and there can be no assurance as to when or if we will fully remediate such material weaknesses. Our plan to remediate the material weaknesses in our internal control over financial reporting includes utilizing a portion of the working capital from our IPO to increase staffing within our accounting infrastructure sufficient to facilitate proper segregation of accounting functions and to enable appropriate review of our internally prepared consolidated financial statements. In addition, we plan to retain outside consultants with expertise in technical accounting and SEC reporting for public company registrants.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) and Rule 15d-15(b) of the Exchange Act, our management, including our principal executive officer and our principal financial officer, conducted an evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q of the effectiveness of the design and operation of our disclosure controls and procedures. In designing and evaluating our disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.

Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

There is an inadequate segregation of duties consistent with control objectives. Our management is composed of four persons, resulting in a situation where limitations on segregation of duties exist. Management has engaged a third-party specialist to review our current internal controls and recommend design improvements to address the segregation of duties given the limited number of employees.

We can give no assurance that additional weaknesses in our internal control over financial reporting will not be identified in the future. Our failure to implement and maintain effective internal control over financial reporting could result in errors in our financial statements that could result in a restatement of our financial statements and cause us to fail to meet our reporting obligations.

Changes in Internal Control over Financial Reporting

During the three months ended September 30, 2026, we completed the implementation of a new enterprise resource planning system. Our condensed consolidated financial statements for the quarter were prepared using the new system. In connection with the implementation, we updated the processes and controls affected by the new system, including our controls over the consolidation of our subsidiaries and foreign currency translation, and we will continue to evaluate these controls as the system matures. Except as described above, there were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations over Internal Controls

Our management, including our principal executive officer and principal financial officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives. However, due to the material weaknesses in our internal control over financial reporting described elsewhere in this Quarterly Report on Form 10-Q, management concluded that our disclosure controls and procedures were not effective as of September 30, 2026.

Management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable,

31


not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

32


PART II—OTHER INFORMATION

From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Item 1A. Risk Factors.

In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors described in Part II, Item 1A, "Risk Factors," of our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026, filed with the SEC on May 14, 2026 and August 14, 2026, respectively, which could materially affect our business, financial condition or future results. For a discussion of risks relating to our pending acquisition of Ratel Robotics, see the risk factors under the heading "Risk Factors" in our definitive proxy statement for the special meeting of stockholders, filed with the SEC on October 6, 2026, which are incorporated herein by reference. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also materially and adversely affect our business, financial condition or future results. Except as set forth below, there have been no material changes from the risk factors described in those reports.

We will need to raise additional capital to fund our operations and to repay the Promissory Note, if drawn, and our ability to transfer cash from Ratel is subject to restrictions.

We expect our existing cash and cash equivalents, together with borrowings available under the Promissory Note, to fund our operations and the remaining cash consideration for the Ratel acquisition for at least the next twelve months. All amounts outstanding under the Promissory Note are due on January 16, 2028. The note restricts our ability to incur other indebtedness and liens, and it contains events of default that, if they occur, would permit the Investor to accelerate repayment and to decline to fund further advances. We will need to raise additional capital to repay the note, if drawn, and to fund our operations beyond that period. ELOC proceeds depend on the market price and trading volume of our common stock, which are outside our control. Ratel’s cash flows depend in part on Ratel obtaining new orders, including customer prepayments, that are not yet under contract, and on Ratel’s continued operations in Ukraine during the ongoing war, and cash held by Ratel is located in Ukraine and is subject to the currency controls of the National Bank of Ukraine and to tax on distributions, which may limit or delay its transfer to us. If we cannot raise additional capital when needed, on acceptable terms or at all, we may be required to delay, reduce or eliminate operations, and substantial doubt about our ability to continue as a going concern could arise again.

It is not possible to predict the actual number of shares of our common stock we will sell under the Purchase Agreement, or the actual gross proceeds resulting from those sales or the dilution to stockholders from those sales. Further, our inability to access a part or all of the amount available under the Purchase Agreement, in the absence of any other financing sources, could have a material adverse effect on our business.

 

Pursuant to the Purchase Agreement, Lucid has committed to purchase up to 3,000,000 shares of common stock from us, subject to certain limitations and conditions set forth in the Purchase Agreement. The shares of our common stock that may be issued under the Purchase Agreement may be sold by us to Lucid at our discretion from time to time over a 24-month period from the date of the Purchase Agreement. The facility commenced on June 15, 2026 upon effectiveness of the related resale registration statement. From commencement through September 30, 2026, we sold 654,734 shares of common stock under the facility for aggregate gross proceeds of approximately $27.2 million. Because the average price of our sales under the facility has been below the Base Price defined in the Purchase Agreement, absent stockholder approval we may sell no more than an additional 1,586,196 shares under the facility.

We generally have the right to control the timing and amount of any sales of our common stock to Lucid under the Purchase Agreement. Sales of our common stock to Lucid under the Purchase Agreement will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Lucid all or some of the common stock that may be available for us to sell pursuant to the Purchase Agreement.

Because the purchase price per share of common stock to be paid by Lucid for additional common stock that we may elect to sell to Lucid under the Purchase Agreement, if any, will fluctuate based on the market prices of our common stock at the time we make such election, it is not possible for us to predict, as of the date of this quarterly report and prior to any such future sales, the number of additional shares of common stock that we will sell to Lucid under the Purchase Agreement, the purchase price per share that Lucid will pay for such additional shares of common stock purchased from us under the Purchase Agreement, or the aggregate gross proceeds that we will receive from such future purchases by Lucid under the Purchase Agreement, if any.

33


Even if we elect to sell to Lucid all of the 3,000,000 shares of common stock pursuant to the Purchase Agreement, depending on the market price of our common stock at the time we elect to sell such shares to Lucid, the actual gross proceeds from the sale of all such shares may be substantially less than the amount available to us under the Purchase Agreement, which could materially and adversely affect our liquidity position. Further, if we are unable to access all or a portion of the amount available under the Purchase Agreement to meet our liquidity needs, we may be required to seek other financing sources and utilize more costly and time-consuming means of accessing the capital markets, which could have a material adverse effect on our business, liquidity and cash position.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

On November 16, 2026, the Company issued the Promissory Note to the Investor in a principal amount of up to $10.0 million. The Company may pay interest under the Promissory Note, and any prepayment premium, in shares of its common stock valued at $8.73 per share (the closing price per share of common stock on the Nasdaq Capital Market on the trading day prior to the entry into the Promissory Note), subject to certain conditions as described therein. Additionally, share issuances are subject to certain limitations, including (i) a beneficial ownership limitation of 4.99% of the common stock outstanding on the date of issuance, and (ii) absent stockholder approval, total issuances may not exceed 19.99% of the shares outstanding on November 16, 2026.

The Promissory Note and any shares issuable under it were not registered under the Securities Act and, instead, were issued in reliance on the exemption provided by Section 4(a)(2) of the Securities Act. No shares of common stock have been issued under the Promissory Note as of the date of this Quarterly Report. Additional terms of the Promissory Note are described in Item 5 below.

Use of Proceeds

On March 18, 2026, we completed our IPO, in which we issued and sold 3,450,000 shares of our common stock, including the full exercise by the underwriters of their option to purchase 450,000 additional shares of our common stock, at a public offering price of $5.00 per share, which resulted in gross proceeds to the Company of approximately $17.3 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The proceeds from the IPO are being used to fund ongoing operations, including expansion of capabilities and our product offerings, hiring employees, integration with the hardware of drone manufacturers, and for working capital and other general corporate purposes. A portion of the proceeds from the IPO is also being used to in-license, acquire and invest in products, technologies and businesses.

The offer and sale of all of the shares of our common stock in our IPO was effected through a Registration Statement on Form S-1 (File No. 333-293123) that was declared effective by the SEC on March 16, 2026.

There has been no material change in the planned use of proceeds from our IPO as described in the prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act on March 17, 2026.

Issuer Purchases of Equity Securities

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

Promissory Note

Subsequent to the end of the quarter, on November 16, 2026, the Company issued the Promissory Note to the Investor. The Promissory Note gives the Company a delayed-draw facility of up to $10.0 million. The Company may request advances under the Promissory Note from time to time, subject to customary conditions, including continued Nasdaq listing of its common stock. The Investor has agreed to retain cash and cash equivalents in an amount at least equal to the undrawn amount of the facility. The Promissory Note matures on January 16, 2028, subject to acceleration as described therein.

 

34


The Promissory Note bears interest at 7.00% per annum, payable quarterly in kind or, with the consent of the Investor and subject to the conditions described therein, in shares of common stock. In the event of an event of default, the interest rate increases by 5.00% per annum while any such event of default continues. In connection with the execution of the Promissory Note, the Company paid a $100,000 origination fee and agreed to reimburse up to $35,000 of the Investor’s legal expenses.

The Company may prepay the Promissory Note in whole, but not in part. A prepayment premium of $250,000 applies during the first three months and $500,000 during months three through six, reduced by any interest previously paid in shares. No premium applies after six months.

The Promissory Note contains customary covenants, including limits on additional indebtedness and liens, and a requirement to use proceeds for general corporate and working capital purposes, as well as customary events of default.

The foregoing description of the Promissory Note is qualified in its entirety by the full text of the Promissory Note, filed as Exhibit 10.1 to this Quarterly Report and incorporated herein by reference.

 

10b5-1 Trading Arrangements

From time to time, our officers (as defined in Rule 16a-1(f) of the Exchange Act) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the three months ended September 30, 2026, none of our officers or directors adopted, modified or terminated any such trading arrangements.

35


Item 6. Exhibits.

The documents listed in the Exhibit List, which follows below, are incorporated by reference or are filed with this Quarterly Report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

 

Exhibit

Number

 

Description

2.1

 

Participatory Interests Purchase Agreement, dated September 9, 2026, by and among Swarmer, Inc, Taras Ihorovych Ostapchuk, Mykola Oleksandrovych Paliienko, Taras Ivanovych Murashko, Denys Volodymyrovych Gorovyi and the Direct Sellers party thereto from time to time (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 10, 2026).

3.1

 

Third Amended and Restated Certificate of Incorporation of Swarmer, Inc (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 18, 2026).

3.2

 

Amended and Restated Bylaws of Swarmer, Inc (incorporated by reference from Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 18, 2026).

10.1*

 

Promissory Note, dated November 16, 2026, by and between Swarmer, Inc and the Investor.

31.1*

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

101.SCH

 

Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

# Certain confidential portions of this Exhibit were omitted by means of marking such portions with brackets ([***]) because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.

+ Denotes management compensation plan or contract.

^ Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company undertakes to furnish supplemental copies of any of the omitted schedules upon request by the U.S. Securities and Exchange Commission.

~ In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management’s Report on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference.

36


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Swarmer, Inc

Date: November 16, 2026

By:

/s/ Alexander Fink

Alexander Fink

Chief Executive Officer (U.S.)

 

Date: November 16, 2026

By:

/s/ Brooks Ensign

 

 

Brooks Ensign

 

 

Chief Financial Officer and Treasurer

 

37


Keep reading